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ty In this study the potential of self-help treatment for anxiety disorders in primary care was investigated. Anxiety disorders are prevalent in primary care and the number of studies targeted at this popula-
tion is limited, while it is evident that treatments 
designed for secondary care are usually not feasible 
for primary care because they require too much time 
investment. In the Guidelines for treatment of anxi-
ety disorders developed by the Dutch College of 
General Practitioners (Guidelines), self-help is not 
mentioned as an option, which motivated us to con-
duct this study. From a literature review it followed 
that self-help shows suffi cient effectiveness, but 
that results improve when some additional time is 
available from a supporting fi gure such as a general 
practitioner (GP) to keep the patients in the self-help 
program. 
Subsequently, we developed a self-help manual for 
two prevalent anxiety disorders in primary care, 
panic disorder with or without agoraphobia and 
generalized anxiety disorder, including guidance 
from the GP, resulting in a guided self-help treat-
ment (Manual). In a preliminary study we found 
that application of the Manual was feasible and 
led to improvement in the primary care patients 
treated. The goal of the main study was to compare 
the effectiveness of the Manual with the Guidelines. 
As these Guidelines have not yet been studied for 
their effectiveness, Cognitive Behaviour Therapy 
as practiced in secondary care was used as a third 
treatment type and as “gold standard”. 
The main fi nding of the RCT was that no differ-
ence in outcome was observed between the three 
treatment types. We also investigated the effect of 
comorbidity on long term outcome and found that 
comorbidity with depression led to a lower rate of 
remission, while comorbidity with other anxiety 
disorders did not.
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The main subject of this thesis is the development and the testing on efficacy and 
feasibility of a guided self-help treatment to be used in general practice for the 
prevalent anxiety disorders panic disorder with or without agoraphobia (PA) and 
generalized anxiety disorder (GAD). 
Anxiety disorders are prevalent in general practice: Ormel et al (1994) found a 
prevalence rate of current diagnosis of 10.4% for all anxiety disorders. In primary 
care, PA and GAD have life time prevalence rates of 3.8% and 2.3% (Bijl et al, 1997). 
Patients with anxiety disorders usually worry about their somatic health. As a 
consequence they frequently visit their general practitioner asking for laboratory 
tests, a somatic screening, and referrals to a medical specialist or simply 
reassurance for their worries. Since anxiety disorders often run a chronic course 
when untreated, they form a major burden to the health system. The large appeal 
these patients make upon the health system weighs heavily upon its limited 
capacity (Wittchen, 1988; Yonkers et al, 1996; Bijl et al, 1997). In secondary care 
there is considerable evidence that PA and GAD can be effectively treated with 
psychological treatment (Emmelkamp et al, 1995; Barlow, 2002). Therefore, it seems 
likely that there is a role for psychological treatments adjusted for use in primary 
care. Increasing availability of short effective and suitable treatments for primary 
care would be a welcome solution for the capacity problem. 
GP’s treating their anxiety disorder patients can turn to the anxiety disorder 
guidelines which were published in 1997 by the Dutch College of General 
Practitioners and revised in 2004 (Neomagus et al, 1997; Terluin et al, 2004). A 
problem with these guidelines is that, up till now, their efficacy was not evaluated. 
Some GP’s find them difficult to follow in clinical practice because of the emphasis 
on the application of cognitive behavioural instructions, which they find rather 
complicated and difficult. Therefore, a self-help manual for the most prevalent 







anxiety disorders was developed along the lines of the anxiety disorder guidelines. 
The literature shows that treatment with self-help manuals in anxiety disorder 
patients in primary care is effective (Bower et al, 2001). But former research also 
shows that dropouts are a problem in its use. Since compliance appeared to be 
related to a better treatment effect (Kupshik and Fisher, 1999), the format of guided 
self-help by the GP was chosen. Because PA and GAD are the most prevalent in 
general practice they became the focus of this manual. 
A brief introduction of the clinical picture of PA and GAD is given in chapter 1. (In 
chapter 1 the research questions will also be described.) The literature on the 
efficacy of self-help manuals for anxiety disorders is reviewed in chapter 2. The 
development of the guided self-help manual and a pilot study in a small number of 
patients in order to establish its feasibility is subject of chapter 3. As it appeared 
that such a guided self-help manual is feasible and effective in primary care 
patients with panic disorder and generalized anxiety disorder, we compared its 
differential efficacy with treatment according to the anxiety disorder guidelines of 
the Dutch College of General Practitioners and cognitive behavioural therapy 
(CBT) delivered by experienced therapists. Short-term outcome of this 
Randomized Controlled Trial and its 6 months and 1-year follow-up is described in 
chapter 4. In addition, some prediction analyses were done in chapter 5. 
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The mental disorders listed in the section ‘anxiety disorders’, of the fourth edition 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV, APA, 1994) 
are mainly characterized by severe feelings of anxiety and/or phobic avoidance 
behaviour. Anxiety manifests itself by feelings of apprehension, fearfulness or 
terror with or without a known cause. These feelings are usually associated with 
somatic symptoms such as: shortness of breath, palpitations, dizziness, chest pain 
or nausea. Patients may worry about these somatic symptoms and believe that 
they suffer from an undetected severe medical illness. As a consequence they 
frequently rely upon the health care system. The phobias are characterized by the 
fear of a certain object or situation which is therefore avoided or in case avoidance 
is impossible, endured with marked distress or anxiety. In addition, the anxiety 
and phobic symptoms must lead to clinically significant impairment or distress in 
social and occupational functioning.  
In this thesis we will limit ourselves to panic disorder with or without agoraphobia 
(PA) and generalized anxiety disorder (GAD), as these syndromes are the anxiety 
disorders the general practitioner is most frequently confronted with. Moreover, 
both anxiety disorders can be treated in general practice. Below, a brief overview 
concerning these disorders is prescribed. We will go into the clinical picture, 
diagnosis, epidemiology, comorbidity, assessment and treatment. 
 
 








Patients with PA suffer from unexpected panic attacks, which are discrete periods 
of intense fear or discomfort, accompanied by physical symptoms such as 
palpitations, chest pain and breathlessness in addition to the fear of dying by a 
heart attack. After the first panic attack, patients often seek help at the first aid 
department of a hospital. In most cases extensive physical examination follows 
without an explanation for the occurrence of the panic symptoms. Other patients 
visit their general practitioner (GP) with complaints of avoiding travelling by 
public transportation and busy shops. These patients are afraid of having a panic 
attack at such places, and may feel depersonalized, dizzy, and are afraid to faint. 
Avoidance of such situations where a panic attack may occur is called 
agoraphobia. Most patients with panic disorder suffer from agoraphobia as well. 
Places which are avoided include busy shops, waiting in a cue, public 
transportation, travelling by car, visiting cinema, doing physical exercises, being 
outside the home alone and confined closed places such as elevators or toilets. 
When patients have company of someone they trust and who can help in case of a 
panic attack, the agoraphobic avoidance usually is less severe than when alone. 
Some people speak openly about their agoraphobic avoidance, others, however, 
feel ashamed and conceal their fears, as for example a house wife who is asking her 
husband to do all shopping in the evening for one week together, thus avoiding 
shopping alone and subsequently feeling ‘unreal’.  
Patients with GAD have as their main characteristic that they worry excessively 
and feel anxious about possible dangers and problems which could arise in the 
future. They worry for example about their health and that of their children and 
spouse, about their housing, finances and their job. They are afraid that they are 
not able to cope with these problems. Patients are not able to control their worries. 
They continuously feel restless, hunted, tense and nervous. The chronic worrying 
and anxiety are accompanied by physical symptoms including fatigue, muscle 
tension, dry mouth, nausea, palpitations, dizziness, diarrhoea and transpiration. 
Because patients have the feeling they always walk on the edge to cope with daily 
life, they minimize contact with others and limit their activities which they 
experience as most burdensome. Sometimes they try to prevent worrying by 
arranging an overloaded day programme, making them exhausted. Some try to 
check their spouse and children by calling frequently to be sure nothing bad is 
going on at that moment. Most patients with generalized anxiety disorder worry 
about worrying (‘meta-worry’). They worry that they should lose their mind by 
worrying, that it is not normal to worry and that they are not able to control their 
worry. 







Patients with anxiety disorders usually worry about their somatic health. As a 
consequence they frequently visit their general practitioner asking for laboratory 
tests, a somatic screening, and referrals to a medical specialist or simply 
reassurance for their worries. Since PA and GAD are both prevalent disorders and 
often run a chronic course when untreated, they form a major burden to the health 
system (Bijl et al, 1997; Wittchen et al, 2002). PA patients make heavy demands on 
primary care services (Sherbourne et al, 1996). Both anxiety disorders are 
associated with considerable disability and inappropriate healthcare utilisation 
(Katon et al, 1990; Wittchen et al, 2002). Patients with pure GAD were associated 
with disability, high utilization of health care resources and suicidality (Wittchen 
et al, 2002). 
As a consequence of these anxiety disorders, patients are disabled in their social 
and occupational functioning. Until recently, patients with GAD were dismissed as 
‘worried well’, implying that they there really is no burden of this disorder. 
However, GAD patients were found to be even more disabled than patients with 
panic disorder (Hoehn-Saric, 1981; Wittchen et al, 2002) while in a second study the 
impairment of GAD was found to be comparable with the impairment of PA 
(Nisita et al, 1990). The latter finding was supported by a study comparing 357 
patients with GAD and/or PA (Massion et al, 1993). No significant differences 
were found between both disorders on suicide attempts (about 10% in both 
disorders), receiving disability benefit (about 25% in both disorders), receiving 
public assistance (about 35% in both disorders), and impaired social functioning 
(about 45% in both disorders). 
DSM-IV diagnostic criteria and diagnosis 
Both panic attacks and agoraphobia are part of different anxiety disorders. They 
have no diagnostic value on their own, and can not be diagnosed as separate 
conditions. The criteria for panic attacks and agoraphobic avoidance, defined in the 
DSM-IV (APA, 1994 pages 395-397), are presented in the tables 1 and 2. 
According to the DSM-IV, PA is diagnosed when panic attacks are unexpected and 
when at least one of the attacks has been followed by one month (or more) of 
persistent concern about having additional attacks, worry about the implications of 
the attacks or its consequences, or a significant change in behaviour related to the 
attacks (APA, 1994, page 402). The panic attacks are not due to the direct 
physiological effects of a substance (e.g., use of drug or medication) or general 
medical condition (e.g., hyperthyroidism). The panic attacks must not be better 
accounted for by another mental disorder, such as social phobia, specific, 







obsessive-compulsive disorder, posttraumatic stress disorder, or separation 
anxiety disorder. 
When a patient with PA is also extremely afraid of entering public places like 
shopping malls, trains, cinemas or other situations from which escape would be 
difficult or in which help would not be available in case of a panic attack, this 
person is said to have panic disorder with agoraphobia. 
 
Table 1: DSM-IV criteria for panic attack 
A discrete period of intense fear or discomfort, in which four (or more) of the following 
symptoms developed abruptly and reached a peak within 10 minutes: 
1. palpitations, pounding heart, or accelerated heart rate 
2. sweating 
3. trembling or shaking 
4. sensations of shortness of breath or smothering 
5. feeling of choking 
6. chest pain or discomfort 
7. nausea or abdominal distress 
8. feeling dizzy, unsteady, light-headed, or faint 
9. derealisation (feeling of unreality) or depersonalisation (being detached from oneself) 
10. feeling of losing control or going crazy 
11. fear of dying 
12. paresthesias (numbness or tingling sensations) 
13. shills or hot flushes 
DSM-IV=diagnostic and statistical manual of mental disorders, fourth edition 
 
Table 2: DSM-IV criteria for panic disorder with or without agoraphobia 
A. Both (1) and (2): 
recurrent unexpected panic attacks 
at least one of the attacks has been followed by one month (or more) of one (or more) of 
the following: 
persistent concern about having additional attacks 
worry about the implications of the attack or its consequences (e.g., losing control, having 
a heart attack, “going crazy”) 
a significant change in behaviour related to the attacks 
B. Presence or absence of agoraphobia (with or without agoraphobia) 
C. The panic attacks are not due to the direct physiological effects of a substance (e.g., a 
drug of abuse, a medication) or general medical condition (e.g., hyperthyroidism). 
D. The panic attacks are not better accounted for by another mental disorder, such as social 
phobia (e.g., occurring on exposure to feared social situations), specific phobia (e.g., on 
exposure to a specific phobic situation), obsessive-compulsive disorder (e.g., on exposure 
to dirt in someone with an obsession about contamination), posttraumatic stress disorder 
(e.g., in response to stimuli associated with a severe stressor), or separation anxiety 
disorder (e.g., in response to being away form home or close relatives). 
DSM-IV=diagnostic and statistical manual of mental disorders, fourth edition 
 
 







Table 3: DSM-IV criteria for agoraphobia 
A. Anxiety about being in place or situations from which escape might be difficult (or 
embarrassing) or in which help may not be available in the event of having an unexpected 
or situational predisposed panic attack or paniclike symptoms. Agoraphobic fears typically 
involve characteristic clusters of situations that include being outside the home alone; 
being in a crowd or standing in a line; being on a bridge; and travelling in a bus, train, or 
automobile. Note: Consider the diagnosis of specific phobia if the avoidance is limited to 
one or only a few specific situations, or social phobia if the avoidance is limited to social 
situations. 
B. The situations are avoided (e.g., travel is restricted) or else are endured with marked 
distress or with anxiety about having a panic attack or panic like symptoms, or require the 
presence of a companion. 
C. The anxiety or phobic avoidance is not better accounted for by another mental disorder, 
such as social phobia (e.g., avoidance limited to social situations because of fear of 
embarrassment), specific phobia (e.g., avoidance limited to a single situation like 
elevators) obsessive-compulsive disorder (e.g., avoidance of dirt in someone with an 
obsession about contamination), posttraumatic stress disorder (e.g., avoidance of stimuli 
associated with a severe stressor), or separation anxiety disorder (e.g., avoidance of 
leaving home or relatives). 
DSM-IV=diagnostic and statistical manual of mental disorders, fourth edition 
 
GAD is defined as unrealistic or excessive anxiety and worry, present during at 
least six months. The anxiety and worry is associated with at least three physical 
symptoms like restlessness or feeling on edge, being easily fatigued, difficulty 
concentrating or mind going blank, irritability, muscle tension, or insomnia. The 
focus of the anxiety and worry is not confined to features of another Axis I 
disorder (e.g., the anxiety or worry is not about having a panic attack (as in panic 
disorder), being embarrassed in public (as in social phobia), being contaminated 
(as in obsessive-compulsive disorder), being away from home or close relatives (as 
in separation anxiety disorder) gaining weight (as in anorexia nervosa), having 
multiple physical complaints (as in somatisation disorder), or having a serious 
illness (as in hypochondriasis), and the anxiety and worry do not occur exclusively 
during posttraumatic stress disorder. The anxiety, worry, or physical symptoms 
cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning. The disturbance is not due to the direct 
physiological effects of a substance (e.g., a drug of abuse, a medication) or a 
general medical condition (e.g., hyperthyroidism) and does not occur exclusively 












Table 4: DSM-IV criteria for generalized anxiety disorder 
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for 
at least six months, about a number of events or activities (such as work or school 
performance). 
B. The person finds it difficult to control the worry. 
C. The anxiety and worry are associated with three (or more) of the following six symptoms 
(with at least some symptoms present for more days than not for the past six months). 
• restlessness or feeling keyed up or on edge 
• being easily fatigued 
• difficulty concentrating or mind going blank 
• irritability 
• muscle tension 
• sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep) 
D. The focus of the anxiety and worry is not confined to features of an Axis I disorder (e.g., the 
anxiety or worry is not about having a panic attack (as in panic disorder), being 
embarrassed in public (as in social phobia), being contaminated (as in obsessive-
compulsive disorder), being away from home or close relatives (as in separation anxiety 
disorder) gaining weight (as in anorexia nervosa), having multiple physical complaints (as 
in somatisation disorder), or having a serious illness )as in hypochondriasis), and the 
anxiety and worry do not occur exclusively during posttraumatic stress disorder. 
E. The anxiety, worry, or physical symptoms cause clinically significant distress or impairment 
in social, occupational, or other important areas of functioning. 
F. The disturbance is not due to the direct physiological effects of a substance (e.g., a drug 
of abuse, a medication) or a general medical condition (e.g., hyperthyroidism) and does 
not occur exclusively during a mood disorder, a psychotic disorder, or a pervasive 
developmental disorder. 
DSM-IV=diagnostic and statistical manual of mental disorders, fourth edition 
 
PA and GAD are diagnosed on the basis of a psychiatric interview. A medical 
examination may be needed to exclude the presence of physical disorders that can 
cause the symptoms of panic or generalized anxiety. Well-known causes of panic-
like symptoms are hyperfunction of the thyroid, hypoglycemia and 
pheochromocytoma. The use of psychoactive substances like caffeine, cannabis or 
cocaine and the withdrawal from benzodiazepines or alcohol may also produce 
panic and anxiety. In all these situations the diagnosis PA or GAD cannot be 
established because of exclusion criteria in the DSM. Instead, the patient is 
diagnosed anxiety disorder due to a general medical condition with panic 
attacks/general anxiety or substance-induced anxiety disorder with panic 
attacks/generalized anxiety. 
 








In Table 5 the prevalence in primary care of PA (lifetime 3.8%) and GAD (lifetime 
2.3%) are presented as found in the Netherlands NEMESIS study (Bijl et al, 1997). 
These data confirm earlier American research (Regier et al, 1988) indicating that 
these anxiety disorders are prevalent in the general population. PA and GAD are 
more common in females than in males. In contrast to GAD, PA has an acute onset, 
with the occurrence of the first unexpected panic attack. The peak prevalence lies 
in the third decade of life. GAD develops gradually with a mean age of 23 years 
(Thyer et al, 1985). Untreated, PA and GAD run a chronic course with a waxing 
and waning of symptoms (Wittchen 1988; Yonkers et al, 1996). 
 
Table 5: prevalence of PA and GAD from the Netherlands ‘NEMESIS’ study in percent by DSM III R criteria in 
general practice, and prevalence of PA from the American ‘E.C.A.’study in percent by DSM III criteria in 
general population 
 ‘NEMESIS’ study ‘E.C.A.’ study 




prevalence PA  
%) 
1-month 1.5 (0.1) 0.8 (0.1) 0.5 (0.1) 
6-months 2.2 (0.2) 1.2 (0.1) 0.8 (0.1) 
life-time 3.8 (0.2) 2.3 (0.2) 1.6 (0.1) 
NEMESIS=Netherlands Mental Health Survey and Incidence Study. DSM-III-R= diagnostic and statistical manual of mental 
disorders, third revised edition. ECA=Epidemiologic Catchment Area. DSM-III = diagnostic and statistical manual of mental 
disorders. PA=panic disorder. GAD=generalized anxiety disorder. 
 
Diagnosis in secondary and primary care 
A reliable way of diagnosing PA and GAD is the use of the Structural Clinical 
Interview for Psychiatric Disorders (SCID-IV; First et al, 1997). In this structured 
interview patients are systematically inquired about the presences of the DSM-IV 
criteria of the disorders. The main advantage is high reliability and validity of this 
measurement. Disadvantage, however, is the duration of the SCID, which may last 
up to one and half hour. With the SCID an overall kappa was found of .85 (0.06), 
range = .71-.97, being an excellent level of agreement (Ventura et al, 1998). 
However, the SCID is too time consuming for use in primary care. An alternative 
reliable way of diagnosing PA and GAD in primary care is the use of the Primary 
Care Evaluation of Mental Disorders (PRIME-MD; Spitzer et al, 1994). With the 
PRIME-MD an overall kappa was found of .71. PRIME-MD was developed as a 
screening instrument but its administration time has limited its clinical usefulness. 
A self-administered PRIME-MD Patient Health Questionnaire (PHQ) has been 
developed. This self-report questionnaire (PHQ) has comparable diagnostic 







validity to the PRIME-MD, and is more efficient to use in primary care settings. 
With the PHQ an overall kappa was found of .65 (Spitzer et al, 1999). 
Recognition of GAD and PA in primary care 
It appears that the GP recognizes less than half of psychological problems (Ormel 
et al, 1991; Satorius et al, 1993). These studies demonstrated that physician 
recognition of anxiety disorders is poorer than that of depression in primary care 
settings. One study suggested that PA patients were more likely to be missed in 
primary care when patients are known with other medical illnesses (Roy-Byrne et 
al, 2000a). Another explanation of poor recognition may be due to a weak 
presentation of the anxiety symptoms by the patients. Particularly, when patients 
demonstrated physical type of symptoms recognition of anxiety disorders will be 
more difficult. Sometimes general practitioners interpret the presented symptoms 
for example as a consequence of the personality structure of the patient (Jenner et 
al, 1995).  
 It has long been noticed that the majority of mental illnesses seen in community 
surveys have not been referred to the mental health services. There is a filtering 
process at work between the community and the mental health in-patient 
treatment. The framework consisted of five levels: 1) community; 2) primary care 
(total); 3) primary care (identified); 4) Mental illness services (total); and 5) Mental 
illness services (in-patients) (Goldberg & Huxley, 1992). In our study we will focus 
on primary care-identified patients. 
Comorbidity 
PA and GAD appear to be frequently comorbid with other anxiety disorders, 
mood disorders and substance related disorders. In early clinical research high 
comorbidity levels for especially GAD were found. This led to the suggestion of 
GAD to be a ‘severity marker’of other syndromes rather than a separate disorder. 
However, later studies in the general population showed that the proportion of 
comorbid disorders in GAD was about as large as in other disorders. Apparently, 
comorbidity in GAD is associated with help-seeking behaviour (Wittchen et al, 
1994). 
In addition, in the Wittchen et al (1994) study it was found that in 9.6% of the cases 
GAD was the only disorder diagnosed, indicating that GAD is indeed an 
independent disorder. Another 12,2% reported that the age of onset of GAD was 







earlier than that of any other comorbid disorder. Together, these patients with 
primary GAD make up approximately one fifth (21.8%) of all GAD cases. This was 
confirmed by Maier et al (2000), who found that in about 25% of the cases in 
general practice GAD is the only disorder present. 
In table 6 comorbidity patterns for PA and PAD, derived from the ‘NEMESIS’ 
study are presented (Ravelli et al, 1998). The clinical relevance of diagnosing these 
disorders with or without comorbid disorders is concerned with the fact that 
patients with comorbid disorders are more severely and chronically ill, more 
disabled, utilize services more frequently and are more difficult to treat (Angst & 
Vollrath, 1991; Roy-Byrne et al, 2000b). However targeted CBT for panic disorder 
has beneficial effects on comorbidity over the longer term (Tsao et al, 2005). 
 
Table 6: Co-morbidity in panic disorder and generalized anxiety disorder from The Netherlands ‘NEMESIS’ 
study in percent (%) by DSM-III-R criteria. 
 PA Agorafobie Specific phobia Social phobia OCD GAD 
PA - -* 12 17 34 23 
GAD 26 21 11 17 25 - 
NEMESIS=Netherlands Mental Health Survey and Incidence Study. DSM-III-R= diagnostic and statistical manual of mental 
disorders, third revised edition. PA=panic disorder. GAD=generalized anxiety disorder. OCD=obsessive compulsive disorder 
All associations are significant. *=n<5 
 
Treatment 
In secondary care there is considerable evidence that PA and GAD both are 
effectively treated with pharmacological and psychotherapeutic treatments 
(Emmelkamp et al, 1995; Barlow, 2002). Although there are some differences 
between the treatments for PA and GAD, we limit ourselves to the similarities. 
Pharmacological treatment consists mainly of antidepressants, while effective 
psychotherapeutic interventions comprise cognitive-behavioural treatment (CBT). 
These treatments improve anxiety symptoms, panic attacks, worry and avoidance 
behaviour. 
The major body of research has been done in patients with PA. In the short-term, 
antidepressants and CBT are comparably effective for patients with panic disorder 
without agoraphobia. However, in case patients suffer from agoraphobic 
avoidance behaviour as well, the combination of antidepressants with exposure in 
vivo is superior to antidepressants and CBT alone (Van Balkom et al, 1997). In the 
long-term, these treatments remain effective, and the combination treatment 
remains superior over its elements (Bakker et al, 1998). Up till now, in GAD, no 
comparisons have been made between antidepressants and CBT. The limited 







research into long-term outcome indicates that treatments remain effective. Rates 
of quality care for anxiety disorders are moderate to low in university-affiliated 
primary care practices. Although an appropriate type of pharmacotherapy was 
frequently used, it was often of inadequate duration. CBT was markedly 
underused. These findings emphasize the need for practice guidelines and 
implementation of quality improvement programs for anxiety disorders in primary 
care (Stein et al, 2004). 
The Dutch College of General Practitioners has recently updated the anxiety 
disorder guidelines (Neomagus et al, 1997; Terluin et al, 2004). As these guidelines 
are evaluated in the main study of this thesis, we describe them briefly below. 
Next, we discuss CBT in more detail, and finish with the developed self-help 
manual for PA and GAD which is also tested in the main study. 
Anxiety disorder guidelines by the Dutch College of General 
Practitioners 
In 1989 the Dutch College of General Practitioners (NHG) [Nederlands Huisartsen 
Genootschap] published their first practice guideline. This guideline, which was 
concerned with the treatment of Diabetes Mellitus type II in the general 
practitioner’s practice, marked the beginning of a success story. Now, 13 years 
later, more than 75 guidelines have made their debut and the guidelines hold an 
integral place in all initial General Practitioner education programme in The 
Netherlands. It is estimated that the published guidelines cover approximately 
60% of the problems seen in the daily practice. The anxiety disorder guidelines 
belong to this series of guidelines with the aim to improve and support an 
evidence-based general practice of these disorders (Neomagus et al, 1997; Terluin 
et al, 2004). Up till now, the efficacy of the anxiety disorder guidelines has not been 
evaluated yet. The anxiety disorder guidelines pertain to recognition, diagnosis 
and treatment of 6 anxiety disorders. We limit ourselves here to the treatment 
section. 
According to the guidelines treatment starts with extensive information on the 
diagnosed anxiety disorder. The GP informs the patient about the relation of the 
somatic symptoms he experiences and PA/GAD. When needed, a somatic 
screening can be used to reassure the patient that the symptoms experienced are no 
sign of an underlying somatic disease. The diagnoses ‘PA’ and/or ‘GAD’ are 
explicitly named, so that patients know which disorder they suffer from. The GP 
reviews with the patient possible causes for the anxiety symptoms, in order to 







identify factors which induce and maintain panic attacks, anxiety, worry and 
avoidance behaviour. 
Treatment is aimed at the reduction of anxiety symptoms to a level which is 
acceptable for the patient. First, the GP makes a inventory of possible psychosocial 
stressors and the use of psychotropic substances related to anxiety. The use of 
caffeine, alcohol and marihuana should be normalised or minimised in order to 
decrease anxiety symptoms. The GP informs the patient about the role of 
catastrophic cognitions and avoidance behaviour in the maintenance of anxiety 
symptoms. When needed the GP can give the patient simple exposure in vivo 
instructions or exercises, or ask the patient to register his anxiety-related cognitions 
in a diary. 
The anxiety disorder guidelines leave the GP free to refer the patient to a 
psychiatric outpatient clinic, to refer to a physiotherapist for relaxation exercises, or 
to prescribe benzodiazepines, antidepressants and buspirone for GAD. 
Cognitive-behavioural therapy 
Below we discuss CBT for PA and GAD separately. In the main treatment study, 
we used two treatment protocols: one for PA and one for GAD. The protocols were 
highly overlapping and in case of comorbidity the interventions were combined. 
The treatment of PA is largely based on the model of Clark (1986), which has 
proven to be effective in the treatment of PA. Treatment starts with the explanation 
of the model of panic disorder and the rationale of the treatment. The vicious circle 
for panic is explained and automatic catastrophic cognitions are identified. In the 
next step these automatic cognitions are challenged by means of the Socratic 
dialogue. A hyperventilation provocation test may be done to demonstrate the 
overlap of bodily symptoms with a panic attack. It may also be used as a first step 
in challenging the catastrophic misinterpretations of bodily symptoms. In the next 
sessions more catastrophic cognitions are challenged and replaced by more 
realistic and rational cognitions. The patient has to challenge these cognitions at 
home. To strengthen the evidence that the catastrophic way in which the somatic 
symptoms were interpreted is incorrect, behavioural experiments were added. 
Finally, an individual hierarchy is made of situations avoided. To overcome the 
avoidance behaviour, exposure in vivo exercises may be added. 
Treatment of GAD is based on its cognitive behavioural models developed 
(Borkovec & Inz, 1990; Clark, 1989; Wells, 1997/2002) and found effective by 
Durham & Turvey (1987), Butler et al (1991), Borkovec & Costello (1993) en 







Durham et al (1994). Treatment starts with an explanation of this model, 
emphasizing the crucial role of catastrophic and ‘meta’ cognitions. The patients’ 
individual catastrophic cognitions are identified and challenged also with the aid 
of behavioural experiments. Subsequently, alternative and more realistic 
cognitions are formulated. An applied relaxation training is given. Patients 
systematically learn to relax in anxiety provoking situations with the use of an 
audiotape (Öst, 1987). Avoidance behaviour and safety behaviour is identified and 
placed in an individual hierarchy and treated with exposure in vivo and response 
prevention exercises. 
Guided self-help treatment 
Since self-help manuals based on cognitive and behavioural principles are 
relatively easy to administer and do not require large time investments by the 
general practitioner, they may be used in the treatment of anxiety disorders in 
primary care. Up till now, these self-help manuals have been developed and tested 
mainly in mental health specialist care settings (Greist et al, 1986; Gosh et al, 1988). 
Recently, however, several effectiveness studies have been published on self-help 
treatment in primary care patients with anxiety disorders (Milne & Covitz 1988; 
Donnan et al, 1990; Sorby et al, 1991; White, 1995; Kupshik & Fisher, 1999; Sharp et 
al, 2000). Overall, they appear to be somewhat less effective than therapist 
delivered intensive treatments (Tyrer et al, 1988; Gould & Clum, 1993; Sharp et al, 
2000). Follow-up data suggest that the treatment gains of self-help interventions 
sustain from 12 months to 3 years (Gould & Clum, 1993; Lidren et al, 1994; White, 
1998). The major problem of the use of self-help manuals is that of lesser patient 
compliance and the tendency to drop out when difficulties occur in the application 
of the manual (Kupshik and Fisher, 1999). To overcome this problem, in this thesis, 
a guided self-help manual was developed, including several contacts with the GP 
who supports and encourages the patient to continue with the manual. 
The self-help manual studied was written under supervision of two experienced 
cognitive behaviour therapists. Material was used of English booklets with 
contains information in self-help for patients with panic disorder, avoidance and 
generalized anxiety disorder (Butler, 1985, Fennell & Butler, 1985 and Sorby et al, 
1991) and a part of the booklet developed for social phobia with exercises of 
applied relaxation by Öst (1987) (Beek, 1996). The self-help manual comprises an 
introduction, education about anxiety, cognitive techniques, relaxation exercises 
and exposure in vivo. The patient is advised to spread the treatment over 12 
weeks. At the end of each chapter the patient can answer self-control questions. In 
addition, the patient is advised not to carry out the treatment alone, but instead call 







in the help of a friend or relative. When the ‘helper’ is asked, the patient can 
present him the flyer with information about the treatment. Added to the manual 
were an audiotape with relaxation exercises, a registration book, an exercise book 
and a book with the answers to the questions in the manual. 
Research Questions 
The main object of the studies in this thesis pertains to the relative efficacy of 
guided self-help treatment, CBT and anxiety disorder guidelines of the Dutch 
College of General Practitioners in primary care patients with PA and GAD in the 
short-term and long-term. A review, a pilot of the Guided Self-Help Treatment and 
some issues on the prediction of treatment outcome were studied as well. 
Up till now, several effectiveness studies have been published on self-help 
treatment in primary care patients with anxiety disorders. These studies compared 
self-help with waiting lists or with care as usual in primary care or with CBT in 
secondary care. In reviewing these studies systematically, we want to give an 
overview of the present knowledge of the effectiveness and the feasibility of 
treatment with self-help manuals for the anxiety disorders in primary care. This 
review is presented in Chapter 2. 
In Chapter 3 a pilot study is described on the effectiveness and feasibility of the 
developed guided self-help program in five selected primary care patients with PA 
and/or GAD. The content of the self-help manual will be discussed in detail. 
Outcome was assessed with validated measurement instruments which were filled 
out directly before the start with the self-help manual and 12 weeks later. 
In Chapter 4 a 12-week RCT with a 12 and 40 week follow-up period is described 
comparing the relative efficacy of guided self-help treatment, CBT and the anxiety 
disorder guidelines of the Dutch College of General Practitioners. General 
Practitioners were randomised to the two conditions delivered in general practice. 
CBT was delivered by experienced cognitive behavioural therapists in a psychiatric 
outpatient clinic specialised in the treatment of anxiety disorders. Primary care 
patients who met DSM-IV criteria for panic disorder and/or generalized anxiety 
disorder were randomly assigned to receive treatment in primary care or 12 
sessions of CBT. The primary outcome measure was the Spielberger State-Trait 
Anxiety Inventory – state subscale (STAI-state: Spielberger et al, 1970). Secondary 
outcome assessments included well-validated scales measuring other psychiatric 
symptoms and associated features of these disorders. Since the three treatments 
differed mainly in the intensity and complexity of the cognitive behaviour 







techniques used, we hypothesised that the most intensive form (CBT in secondary 
care) would give the best results, followed by manual and with guidelines as a 
significantly poorer third. 
In Chapter 5 a study of the influence of type of comorbidity on the 1-year course of 
a sample of 141 outpatients with panic disorder with or without agoraphobia and 
generalized anxiety disorder receiving different forms of cognitive behaviour 
therapy. This was determined on change scores (linear regression analysis) and 
remission data (Kaplan-Meier survival analysis). Three categories as assessed at 
pretest were compared: no comorbidity, comorbidity among anxiety disorders and 
comorbidity with mood disorders. Primary outcome variable: State-Trait Anxiety 
Inventory State subscale measured at four assessments (0, 12, 24 and 52 weeks). 
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To review effectiveness studies of self-help manuals for anxiety disorders in 
primary care. 
Methods 
A systematic review of six identified randomized controlled trials. In addition to 
outcome the articles were coded on quality variables. 
Results 
The studies included differed with respect to the methodological quality, 
measurements used and size of the study population. Despite these differences, 
global results suggest that a self-help manual is an effective treatment possibility 
for primary care patients with anxiety disorders. The more time was spent to the 
guidance of the self-help manual the higher its effectiveness was. 
 








Treatment with a self-help manual for anxiety disorders may be effective in 
primary care. Data are lacking on the feasibility and cost-effectiveness of these 
manuals. 
Keywords 
Systematic review, anxiety disorders, primary care, self-help manual 
Introduction 
General practitioners (GPs) play an important role in the treatment of patients with 
anxiety disorders because these disorders are highly prevalent in general practice 
(10-20%), (Ormel et al, 1994; Bijl et al, 1997) and these patients can not always be 
treated adequately in secondary care settings due to a limited capacity. As only a 
small number of patients with anxiety disorders remits spontaneously, an 
adequate treatment is necessary for most patients. The GP usually treats anxiety 
disorders with either benzodiazepines or antidepressants. Albeit effective, these 
drugs may have several disadvantages such as the occurrence of undesirable side 
effects, relapse after discontinuation and the risk of dependency. These 
disadvantages may lead to a poor patient compliance and a relatively high dropout 
rate. In contrast, the effectiveness and tolerability of cognitive behavioural therapy 
(CBT) with a small tendency to relapse after treatment has repeatedly been 
demonstrated in the short-term and long-term. Unfortunately it is difficult to 
deliver CBT adequately in primary care, because it requires an extensive training 
of the therapist and should be delivered on a weekly basis in ten to twenty sessions 
of 45 to 60 minutes. It has been attempted to modify CBT into a more efficient, cost-
effective, and affordable treatment (Bond & Dryden, 2002). One of these 
modifications comprises the use of self-help manuals. Since such manuals are 
relatively easy to administer and do not require large time investments, they may 
be used in the treatment of anxiety disorders in primary care. 
Up till now, several effectiveness studies have been published on this subject 
(Bower et al, 2001; Newman et al, 2003).We want to review these studies 
systematically on the effectiveness and the feasibility of treatment with self-help 
manuals for the anxiety disorders in primary care, to identify gaps of knowledge 
and suggest future research. 









We included randomised-controlled trials (RCT) evaluating the effectiveness of 
self-help manuals in the treatment of anxiety disorders in primary care. Self-help 
manuals were defined as booklets or manuals aimed to overcome anxiety 
disorders and designed to be used by the patient himself or in conjunction with 
limited therapist contact. We were especially interested in panic disorder (PD) and 
generalized anxiety disorder (GAD) because these disorders are highly prevalent 
in primary care. Studies with a mixed population, i.e. anxious and depressed 
patients, were excluded when data on the sub-sample with anxiety disorders was 
not separately provided. In an attempt to identify all studies, the quality of the 
study was not used as an exclusion criterion. 
An initial search of the Pub Med, PsycLit/PsycInfo and Cochrane database was 
done for the period 1963 to June 2003, using the keywords ‘anxiety disorders’, ‘PD’, 
or ‘GAD’ in combination with ‘self-help’, ‘general practice’, ‘primary care’ or 
‘family practice’. This search was extended by a manual search of the cross-
references from the included papers. 
Data extraction 
CAvB and AJLMvB independently reviewed the studies selected by filling out a 
coding form. After the studies were coded twice, discrepancies in the two coding 
forms were resolved by referring to the data of the original article. This method 
yielded one coding form per article. The coding form consisted of the following 
items: year of publication, sample size, diagnosis, diagnostic criteria, duration of 
disorder, age, sex, intervention type, duration of intervention, presence and 
duration of follow-up and global results at posttest and at follow-up. Moreover, 
the methodological quality of the studies included was assessed with the 
Amsterdam-Maastricht consensus list, range 0–19 points (Van Tulder et al, 1997). 
Analysis 
In order to get an impression of the magnitude of the results obtained after 
treatment with a self-help manual, effect sizes Cohen’s d were calculated on 
anxiety outcome measures. The effect size was calculated within interventions by 
subtracting posttest from pretest scores and dividing the difference by the pooled 
standard deviation (Hunter & Schmidt, 1990). 







As follows below, it appeared that the studies included differed with respect to the 
methodological quality, the measurements used and the size of the study 
population. Therefore, we decided not to pool the results. Due to the small number 
of studies included, no formal statistical analyses were used, with exception of 
some non-parametric correlations. 
Results 
The initial search yielded a total of 966 reference titles in Pub Med, 293 in 
PsycLit/PsycInfo and five in Cochrane database. After screening abstracts or full 
text of the articles found, four studies and one follow up study were identified on 
the effectiveness of self-help manuals in the treatment of anxiety disorders in 
primary care. A manual search of the cross-references of the articles found, yielded 
two other papers of possible relevance. After reading the full text, six studies and 
one follow up study could be included in this review (see Table 1). 
 







Initial search 966 293 5 
Excluded on abstract/ full text 963 291 5 
No anxiety disorders 299 38 0 
Anxiety disorders mixed with other 
diagnosis 
44 2 0 
No primary care 36 21 0 
No self-help manual (videotape/ computer) 10 9 0 
Review/overview 166 34 1 
Treatment outcome study 146 64 3 
Epidemiology/prevalention study 33 9 0 
Diagnostic study 158 57 0 
Prediction outcome study 21 14 0 
Medical utilization in anxiety disorders 14 6 0 
Other (mainly letters/editorials/ books) 36 37 1 
Included studies & follow up study 3* 2** 0 
* Sorby (1991); Kupshik (1999); Sharp (2000) 
** reference White (1995); White (1998) 
Handsearch reference Milne (1988); Donnan (1990) 
 
Table 2 shows scores on the methodological quality of the included studies 
measured with the Amsterdam-Maastricht-consensus list. Due to the type of the 
intervention investigated, in none of the studies the care provider and the patients 
were blind. Moreover, in none of the studies adverse effects were provided. 







Therefore, the maximum quality score of the studies selected was 16. The quality of 
the studies ranged from moderate (Donnan et al, 1990; Kupshik & Fisher, 1999) to 
good (Sharp et al, 2000). Recency of the study correlated moderately with better 
quality (Spearman’s rank correlation: 0.41; p =0.42). 
 
Table 2: Validity scores of included studies by two independent reviewers measured with the Amsterdam-
Maastricht consensus list 
Authors 
 

















et al  
(2000) 
Validity criteria       
Adequate randomisation 
procedure + + + + + + 
Concealed random allocation of 
treatments 0 - - 0 - + 
Pretest similarity tested - + + + + + 
Control for co-interventions in 
design + - - - - + 
Check for adherence to 
interventions + - + + + + 
Valid outcome measure + + + + + + 
Relevant outcome measure + + + + + + 
Outcome assessor blinded 0 - - - - + 
Care provider blinded - - - - - - 
Patient blinded - - - - - - 
Withdrawals and drop-outs 
(proportion; inequality between 
groups; reasons for 
withdrawal/drop-out reported) 
+ - + + - + 
Identical timing of outcome 
assessment for all intervention 
groups 
+ + + + + + 
Intention-to-treat analysis - - - - - + 
Descriptive criteria       
Specification of eligibility criteria - - + + 0 + 
Description of the interventions + + + + - + 
Follow-up + - - + + - 
Adverse effects - - - - - - 
Statistical criteria       
Sample size: to be presented at 
randomisation and outcome + + + + + + 
Presentations of point estimates 
and distribution measures + + + + - + 
Total score (range 0-19) 11 8 11 12 8 15 
+ present, - absent, 0 not provided 

















Mean duration of 
anxiety problem 









































DSM III >1 months 4.1% 
1-3 months 14.3% 
4-6 months 6.1% 


























102 Anxiety Zung Anxiety 
Scale 
36,4 months 












104 PD + A DSM III-R (1) 26.8 months 








PD=panic disorder. A=agoraphobia. GAD=generalized anxiety disorder. DSM=Diagnostic and Statistical Manual of Mental 












































(i) manual (7) 
(ii) a health education leaflet (5) 
(iii) waiting list control group (6) 





(i) manual (51)  
(ii) care as usual (52)  
 





(I) manual (30) 
(ii) care as usual (19)  
2 months 1>2 - - 
White  
1995 
(i) manual (21) 
(ii) advice only (20) 
(iii) waiting list (21) 
and after three months all CBT 





(i) manual and minimal contact (29) 
(ii) manual and medium contact (23) 
(iii) manual and maximum contact (28) 
1.5 months 1<3 
1=2 
2=3 







(i) manual (29) 
(ii) manual and 2 hours CBT(31)  
(iii) manual and 6 hours CBT (31) 

















Characteristics and outcome of the included studies are shown in Table 3. As 
follows from Table 3, the six studies included differed on the diagnosis included, 
the diagnostic criteria used, the duration of the intervention (range 1-3 months), 
presence of a follow-up period (in three of six studies) and duration of the follow-
up (range 3 months – 3 years). Overall, the study sample was rather small and the 
dropout rate relatively high. In four studies the self-help manual was compared to 
control conditions as a waiting list or care as usual (Milne & Covitz, 1988; Donnan 
et al, 1990; Sorby et al, 1991; White, 1995; White, 1998). Two studies did not find 
significant differences between respectively the manual versus a waiting list (Milne 
& Covitz, 1988) and the manual versus care as usual (Donnan et al, 1990). In 
contrast, the other two studies showed superior outcome of the self-help manual. 
One negative study used a very small sample (each condition included less than 
ten patients) (Milne & Covitz, 1988), while the other negative study had only a 
moderate by large quality score (Donnan et al, 1990). 
Two studies compared the self-help manual with other interventions, characterised 
by increasing guidance or hours of contact (Kupshik & Fisher, 1999; Sharp et al, 
2000). The global results suggest that the more contact the patient received the 
higher the effect of the manual was (see later). It is noteworthy that a self-help 
manual was even effective in a sample of patients with a duration of anxiety 
complaints of more than one year. The small number of follow-up data suggest, 
that the treatment gains of self-help manuals are sustained until after 12 months 
and 3 years (White, 1995; White, 1998). 
In three studies effect sizes could be calculated on anxiety measures. These are 
shown in Table 4. The effect sizes Cohen’s d associated with treatment with a 
manual only varied from 0.38 to 1.74. This large difference is due to the type of 
measurement used and the duration of the study (one month seems rather short to 
overcome anxiety symptoms). In corroboration with global outcome, the 
magnitude of the effect sizes was critically dependent of the additional time spent 



















Number of patients per intervention (n) 
Outcome measures 
  STAI (state) STAI (trait) 
Milne & Covitz  
1988 
(i) manual (7) 
(ii) a health education leaflet (5) 











(i) manual (21) 
(ii) advice only (20) 











(i) manual (29) 
(ii) manual and 2 hours CBT (31)  






SCL-90=symptom checklist 90. HADS=Hospital anxiety and depression scale. STAI=state-trait anxiety 
inventory. GSS=Global symptom severity. CBT=cognitive behaviour therapy. WL=waiting list 
 
Discussion 
We can conclude that treatment with a self-help manual for anxiety disorders in 
primary care may be effective. The magnitude of the effect size Cohen’s d for this 
treatment varied from moderate to large. Moreover, it was found that the more 
time was spent to the guiding of the self-help manual the higher its effectiveness 
was. Even patients with longstanding anxiety symptoms may profit from 
treatment with a self-help manual. None of the studies reported on the feasibility 
in primary care practice. 
The conclusions of the present study are limited, because we could only include six 
studies on this subject. These studies differed with respect to quality, 
measurements and study size and are therefore difficult to compare. Although 
some of the studies only had a moderate quality, validated questionnaires were 
used, making comparison possible with the literature. In a recent meta-analysis 
CBT provided in secondary care for panic and agoraphobia was associated with an 
effect size of 1.25 respectively 0.91 (White, 1998). Most effect sizes of this review are 
somewhat smaller, corroborating with the observation that the more time spent to 
the guiding of the manual the better outcome was. 







Future research should focus on the treatment of well-defined anxiety disorders in 
general practice, the feasibility of using a (guided) self-help manual in this setting 
and the cost-effectiveness especially compared with second-line CBT. 
General practice is an environment of limited resources which aims to provide the 
time and attention a patient needs, but not more. If spontaneous recovery does not 
occur in anxiety disorder patients in primary care, a minimal intervention in the 
form of a self-help treatment may be offered. The results of this study may fit in a 
stepped care approach and suggest that (guided) self-help manual may be a first 
line treatment of anxiety problems in primary care. 
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An analysis in single cases 
Treatment of panic disorder and/or generalized anxiety 
disorder with a guided self-help manual: an analysis in 
single cases 
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Treatment of panic disorder and/or generalized anxiety disorder with a guided 




The aim of this pilot study was to test the effectiveness and feasibility of a new 
guided self-help program in five selected primary care patients with panic disorder 
(PD) and/or generalized anxiety disorder (GAD). Most patients achieved a 
clinically relevant improvement after 12 weeks of treatment with large effect sizes 
Cohens’ d on all measures. Two patients could be considered as recovered 
according to the criteria of Jacobson and Truax. Although all patients appeared to 
be improved on all outcome measures, PD was more easy to treat than GAD. These 
results suggest that a guided self-help manual treatment is an effective treatment 
possibility in the treatment of PD and GAD in primary care. When these results 
can be replicated in a controlled trial in a larger sample, guided self-help treatment 
may be a first line treatment in general practice in a stepped care approach of PD 
and GAD. 
Key words 
Self-help manual, Panic Disorder, Generalized Anxiety Disorder and primary care. 







Theoretical and research basis 
General practitioners (GPs) play an important role in the treatment of patients with 
anxiety disorders because these disorders are highly prevalent in general practice. 
The prevalence of anxiety patients in primary care medical setting has been 
estimated to range between 5% and 20% (Ormel et al, 1994; Sartorius et al, 1993; 
Spitzer et al,1995; Bijl et al, 1997). All these patients can not be treated adequately 
in secondary care settings due to capacity limits. The GP usually treats anxiety 
disorders with either benzodiazepines or antidepressants. Albeit effective, these 
drugs may have several disadvantages such as the occurrence of undesirable side 
effects, relapse after discontinuation, and the risk of dependency. These 
disadvantages may lead to a poor patient compliance and a relatively high dropout 
rate. In contrast, the effectiveness and tolerability of cognitive behavioural therapy 
(CBT) has repeatedly been demonstrated in the short-term and long-term, with a 
small tendency to relapse after treatment. Unfortunately it is difficult to deliver 
CBT adequately in primary care, because it requires an extensive training of the 
therapist, and should be delivered on a weekly basis in ten to twenty sessions of 45 
to 60 minutes. To overcome these disadvantages treatment researchers have 
recently attempted to make CBT more efficient, cost-effective, and affordable 
(Bond & Dryden, 2002). One approach for enhancing efficiency is to make use of 
self-help manuals. 
Since self-help manuals based on cognitive and behavioural principles are 
relatively easy to administer and do not require large time investments from the 
GPs, they may be used in the treatment of anxiety disorders in primary care. Up till 
now, these self-help manuals have been tested mainly in mental health specialist 
care settings. Overall, they appear to be somewhat less effective than therapist 
delivered intensive treatments (Tyrer et al, 1988, Sharp et al, 2000). Follow-up data 
suggest that the treatment gains of self-help interventions were sustained even 
after 12 months (White, 1995; van Balkom et al, 2000). Major problems in the 
feasibility of self-help manuals are the tendency for patients to have a low 
compliance and to stop the use of the manual when difficulties occur. To overcome 
these problems, we applied guided self-help: this includes some contacts with the 
GP who supports and encourages the patient to continue with the manual. 
There is a clear need to investigate the effectiveness of these treatment programs in 
primary care (Beek, 1996). The aim of this pilot study was to test the effectiveness 
and feasibility of a new guided self-help program for primary care patients with 
panic disorder (PD) and generalized anxiety disorder (GAD). 








Patient 1 is a 46-year-old married Caucasian female. She was living with her 
husband and 17-year old daughter. Her 24 years-old son lived on his own. After 
finishing primary school she became a housewife.  
Patient 2 is a 49-year-old divorced, homosexual Caucasian male. Once married he 
found out he had homosexual feelings, leading to a divorce. After finishing high 
school he worked as an illustrator.  
Patient 3 is a 39-year-old single Caucasian female. After finishing high school she 
worked freelance as a marketing researcher.  
Patient 4 is a 60-year-old divorced Caucasian female, living with her son. After 
primary school she started working for one day a week as a housekeeper and was 
a housewife.  
Patient 5 is a 63-year-old widowed female, whose husband died 10 years ago. She 
has two daughters, 37 and 31 years old. After primary school she went to a school 
for domestic economy. She did not graduate, but started working in home care.  
Presenting complaints 
Patient 1 was diagnosed with Panic Disorder (PD) with agoraphobia and 
dysthymic disorder. When she started treatment with the self-help manual, she 
suffered from panic attacks for 8 years. During these attacks she experienced 
palpitations, shortness of breath, dizziness, fear of loosing self-control and fear of 
dying. She was afraid of having a panic attack in places like elevators, stairs, toilets 
or a queue. She avoided places from where she could not escape easily, such as 
supermarkets, theatres, children’s playgrounds and airplanes. She also avoided 
public transportation, walking alone in the street, going far away from home alone 
and thinking of illnesses or accidents. For others, she tried conceal her anxiousness 
when she experienced bodily symptoms like palpitations and breathlessness.  
Patient 2 presented with a diagnosis of PD with agoraphobia and co-morbid 
hypochondriasis and dysthymic disorder. After his divorce, he started with 
drinking alcohol in large amounts. Two years ago he suddenly experienced 
unusual bodily feelings like shaking and a dry mouth. He was afraid of having a 
heart attack. At that moment he was alone in a crowded place buying alcohol in a 
shop. From there, he called the emergency department. As he was told that alcohol 
could induce panic symptoms, he stopped the drinking of alcohol completely. 







However, he remained anxious and lost his job. From then on, he suffered from 
unexpected panic attacks with symptoms of breathlessness, chest pain, stomach 
pain, dizziness, depersonalisation, paresthesias and fear of doing something 
uncontrolled, to faint or to die from a heart attack. He avoided situations from 
which he could not leave easily, like the soccer stadium and crowded places, and 
was afraid to sport. He was also afraid to die of aids or long cancer in spite of 
reassurance by a physician, and felt depressed most time of the day, with sleeping 
problems, poor concentration and feeling helpless. He took 5 mg of oxazepam per 
day, and smoked marihuana on a daily basis to feel more relaxed. 
Patient 3 was diagnosed with PD with agoraphobia and dysthymic disorder. She 
suffered from unexpected panic attacks for 8 years with palpitations, sweating, 
paresthesias, dizziness, shortness of breath, chest pain, nausea, feeling unreal, 
getting warm and cold, fear to loose control or to die of a heart attack or by 
choking. She avoided going out to crowded places like cafes and shops, going 
alone far from home, and small closed places like elevators, busses and airplanes. 
Patient 4 presented with PD with agoraphobia, GAD, social phobia, posttraumatic 
stress disorder and dysthymic disorder. She suffered from unexpected panic 
attacks, with complaints of palpitations, sweating, paresthesias, shortness of 
breath, feeling dizzy and fear to loose control, and avoided situations such as 
going out alone, visiting a birthday, going to church, traveling by bus, train or 
driving a car, being in a supermarket, waiting in a line. From childhood onwards, 
she suffered from excessive worrying most of the day. Recent topics were her 
children, finances, and the health of her mother. These symptoms were 
complicated 18 years ago with a panic attack when she was home, lying on the 
couch. Upset about these symptoms, she called the primary care physician who 
gave her medication to calm down. 
Patient 5 was diagnosed with GAD, PD partly in remission and hypochondriasis. 
She was worried that something bad could happen to her children and felt restless 
and irritated. She suffered from tense muscles. Due to her fear of having cancer, 
she avoided to attend preventive breast examination. Many bodily symptoms were 
interpreted as the evidence of having cancer. She had panic attacks with symptoms 
of palpitations, breathlessness, pain in the chest, stomach pain, dizziness, feeling 
unreal, paresthesias, feeling hot and cold, and was afraid to die. 








Patient 1 experienced her first panic attack at night in bed when she was thinking 
about her son who was on vacation alone and became afraid that he was lost. She 
became anxious, had smothering sensations and paresthesias and was afraid to 
faint. The agoraphobic avoidance started after a panic attack while driving on a 
highway one year later. From now on, her anxiety and avoidance increased and 
she became depressed as well, suffering from insomnia, overeating, and having 
low energy, low self-esteem, poor concentration and feelings of hopelessness. Since 
two years she used daily 75mg of clomipramine (an antidepressant), to which she 
responded only partially. She drank 12 glasses of wine as self-medication weekly. 
Patient 2 received former treatment with hypnosis, psychotherapy on analytic lines 
and fluvoxamine (an antidepressant). These treatment did not affect his anxiety 
symptoms. Since fluvoxamine had appeared ineffective, he had stopped this 
antidepressant.  
Patient 3 underwent his first panic attack immediately after the use of marihuana. 
Due to her symptoms, she became insecure and depressed most of the time with 
complaints of poor appetite, sleeplessness, fatigue, low self-esteem, concentration 
difficulties and feeling helpless. Prior to the self-help treatment she received 
physiotherapy for half a year, with only a small effect on these symptoms. 
Patient 4 had panic attacks every day. After a divorce all her complaints worsened 
thirteen years ago. She avoided to go out alone, to travel with public transport or to 
visit crowded places like churches, supermarkets, birthday parties and weddings. 
After school she became anxious to perform in front of strangers. More and more 
she was afraid of scrutiny by others. Feeling depressed most of the time, she also 
suffered from sleeplessness, fatigue, and a low self-esteem. During her marriage 
her husband assaulted her several times, leading to a post traumatic stress 
disorder. She relived these traumas over and over again and avoided situations 
resembling the assaults. She felt strange and empty as if she was not there, and 
complained of being more irritable, of difficulty concentrating and of being 











Patient 5 started having panic attacks 15 years ago after the death of her husband 
who suffered from a myocardial infarction, multiple sclerosis, lung emphysema 
and bladder cancer. The panic attacks were complicated with worries, when eleven 
years ago her sister and mother died of cancer and her daughter had a baby who 
died at birth. Fifteen years ago she was prescribed oxazepam and haloperidol (an 
antipsychotic drug) by a psychiatrist for one year. She saw a psychologist for 4 
years. 
Assessment 
The patients filled out self-report measurements at 0 and 12 weeks. All measures 
are validated for The Netherlands and show good psychometric properties. 
(1) General Health Questionnaire (GHQ-12; Goldberg & Williams, 1988). This 
questionnaire of 12 items is a reliable and valid rating scale to assess an overall 
self-rated measure of well being (range: 0-12). According to the formulas 
developed by Jacobson and Truax (1991) the reliable change score on the GHQ-12 
is a change of more than 3 points. The recovery criterion on the GHQ-12 is a 
posttest score of less than 3. (Koeter & Ormel, 1991; Piccinelli et al, 1993; Van 
Hemert et al, 1995). 
(2) Fear Questionnaire (FQ; Marks & Mathews; 1979). This questionnaire, 
consisting of 20 items, is a reliable and valid rating scale to assess severity of 
avoidance of several phobic situations (range: 0-160). According to Jacobson and 
Truax (1991) on the FQ total phobia and anxiety/depression subscales the reliable 
change was a score of at least 23 points respectively 11 points. The recovery 
criterion on the FQ subscales differs by sex. Recovered females must score less than 
32 and males 33 on the FQ total phobia subscale. For the FQ anxiety depression 
subscale a score of 13 for females and 14 for males was required (Marks and 
Mathews, 1979; Arrindell et al, 1984; Mizes & Crawford, 1986). 
(3) Spielberger State-Trait Anxiety Inventory (STAI; Spielberger, Gorsuch & 
Lushene, 1970). 
This self-report questionnaire measures reliable and valid the presence and 
severity of general anxiety with 20 anxiety state and 20 anxiety trait items (range: 
20-80, Van der Ploeg, 1980). 
(4) Lehrer-Woolfolk Anxiety Symptom Questionnaire (LWASQ; Lehrer & 
Woolfolk, 1982). 







This 36-item questionnaire is a reliable and valid measurement of severity of 
somatic, cognitive and behavioural aspects of anxiety (range: 36-180; Scholing & 
Emmelkamp, 1992). 
Case conceptualization 
For this pilot study, three GPs were asked to screen patients visiting their practice 
on a probable anxiety disorder with the short and simple screening interview of 
Goldberg et al (1988). When patients were able and willing to travel to our 
outpatient clinic and probably wanted to work on their problems with a self-help 
manual with guidance from a medical doctor, the GPs made an appointment for 
their patient. With the Dutch version of the Anxiety Disorder Interview Schedule 
(ADIS IV; Di Nardo et al, 1983) a trained medical doctor supervised by a 
psychiatrist, diagnosed patients with a main diagnosis of PD and/or GAD 
according to the DSM-IV (APA, 1994). Moreover, patients were excluded using 
more than 30mg oxazepam daily. In the case patient used other benzodiazepines 
the dosage of this benzodiazepine was converted to the equivalent doses of 
oxazepam. We included patients with these main disorders only, because the self-
help manual focuses primarily on these disorders. However, included patients 
were allowed to have secondary diagnoses as for example dysthymic disorder or 
other anxiety disorders. We did not include patients who had received cognitive or 
behavioural treatment in the past, because the self-help treatment used cognitive-
behavioural elements. Patients were allowed to take psychopharmacological 
drugs, provided by their GP’s, when dosages were kept constant during the self-
help treatment. Five patients were included and completed treatment with the self-
help manual (one male, four females; mean age 51.4 years, range 39-63 years; mean 
duration of complaints 9.2 years, range 21 months to 15 years; three patients with 
PD, two patients with co-morbid GAD and PD).  
Course of treatment: the self-help manual 
The first author wrote the self-help manual with supervision of two experienced 
cognitive behaviour therapists. The self-help manual was discussed with the 
patient in 5 sessions in the course of 12 weeks. To be feasible in general practice, 
each session should not last more than 20 minutes. All patients were treated 
individually. The patients were instructed not to change the doses of 
benzodiazepines or antidepressants during these 12 weeks. 







In the first session information was given about the treatment with the self-help 
manual. All patients received the self-help manual, a registration book, an exercise 
book, and a relaxation tape with exercises of applied relaxation by Öst and a flyer 
with information for a helper. They were told to reserve enough time for the 
treatment and to practice every week for at least three hours, throughout the week. 
In the following four sessions the patients were asked whether they had questions 
about the part of the manual they worked on and whether they had carried out 
their homework as instructed. The therapist reinforced achievements and tried to 
motivate the patient to take enough time to practice and do homework. In case the 
patient could not follow the schedule, the therapist tried to solve this problem 
together with the patient. In the fifth and last session follow-up treatment was 
discussed. 
The self-help manual comprises an introduction, information about anxiety, 
cognitive techniques, relaxation exercises and exposure in vivo (Fennell & Butler, 
1985; Butler, 1985; Beek, 1996). At the end of each chapter the patient is asked to 
answer self-control questions. In the introduction, the goal of the treatment to 
overcome anxiety problems in 12 weeks is described. In the first chapter the 
manual explains how to spread the exercises over 12 weeks. In addition, the 
patient is advised not to carry out the treatment alone, but with the help of a friend 
or relative. For the ‘helper’ the flyer is available with information about the course 
of treatment and information about how to help the patient, such as assist in doing 
the exercises and evaluate exercises afterwards. In difficult periods the helper can 
motivate the patient to continue treatment. The patient is instructed to choose 
someone whom he trusts and who is both firm and patient. The patient is 
instructed to write down every day the time spent with the treatment in a 
registration manual. 
In the second chapter information is given about normal and pathological anxiety 
and the consequences of the latter (bodily sensations, fear of fear, avoidance, loss of 
confidence). Anxiety can be interpreted as a consequence of catastrophic 
misinterpretations of bodily sensations. These bodily sensations are mainly those 
involved in normal anxiety responses. For example when a person has palpitations 
he can misinterpret this as a dangerous heart disease. This may result in fear of a 
heart attack, which is perceived as a threat. The apprehension increases and a wide 
range of bodily sensations like shortness of breath, sweating, and dizziness 
accompanies this state. If these anxiety-produced sensations are again interpreted 
in a catastrophic fashion, a further increase in apprehension occurs. This produces 
a further increase in bodily sensations and results in a vicious circle, which was 







culminate in a panic attack. Other thoughts, which may enhance anxiety feelings, 
are ‘It is very sure that things will go wrong’, ‘I cannot work out this problem’, ‘I 
will faint when everybody is there'. In figure 1 a panic attack according to a 
cognitive perspective is described, based on a figure in Clark (1986) and Wells 
(2002). 
Figure 1:  an example of a panic attack according to a cognitive perspective, based on a figure in Clark 
(1986) and Wells (2002) 
 
In the third chapter a cognitive approach (situation → feelings → thoughts →) is 
described to identify anxious thoughts combined with ways to find alternatives. 
Patients can log their own anxious thoughts in a file. Some examples are provided 
of negative unrealistic automatic thoughts in panic and worrying. Like ‘when I 
have palpitations, I will die of a heart attack’; ‘When I feel dizzy, I will faint’; 
‘When I have a headache, this is a sign of a brain tumor’; ‘When my friend is not 
coming home on time, he will have a car accident’. By describing the situations 
they face while having these feelings of discomfort, some underlying anxious 
thoughts can be identified. For example: Sitting on the cough, watching an exciting 
film having palpitations → anxiety → ‘I have a heart attack’. Or: waiting for a 
husband to come home at 6 o’clock and it is now 5 minutes later →‘He is in a car 
accident’ → anxiety. By writing this down patients can find a connection between 
situations, thoughts and feelings. That is a first step towards changing these 
unrealistic automatic thoughts. Examples of more realistic thoughts of the before 
mentioned examples are provided, such as ‘When I have palpitations it could be 
due to the exciting film I am watching’, or ‘When my husband is home later than 
















anxiety is provided in a question and answer fashion. ‘Can I do something about 
my anxiety problem, even if I was born this way’ is answered with’ It is possible 
that you are more sensitive to having this anxiety problem than other people have. 
This does not mean that you cannot learn to deal with the anxiety at all’. In this 
way, the patient can see if his thoughts are as realistic as he thinks. If he is able to 
change and replace his dysfunctional thoughts by more functional ones his fear 
will decrease. 
In chapter four applied relaxation is introduced. The relaxation training by tape 
starts with progressive relaxation with tension-release of the muscles (step 1). The 
short version (release-only) is introduced by step 2 and cue-controlled 
(conditioned) relaxation is introduced by step 3. Differential relaxation is 
introduced by step 4. The patients are taught rapid relaxation and practice their 
relaxation skills in stressful but non-panic situations by step 5. In step 6 application 
training in naturalistic situations is introduced (Öst, 1987). In addition, the patient 
learns to apply breath control techniques. 
In the last chapter the patient starts with gradual exposure in vivo, by drawing up 
a list of avoided situations. From this list the patient constructs a fear hierarchy. He 
gradually exposes himself to the fearful situations with or without the helper. The 
patient regains confidence by actually doing these things and learning that anxiety 
will go away by practicing over and over again. In the exercise book, every 
situation which is practiced, can be scored with the amount of tension the patient 
feels before, during and after the practice. When a goal is reached, the patient has 
to repeat the exercise, after which he can start with a more difficult exercise. This 
part ends with encouragement to continue exposure and regaining self-confidence, 
by thinking positively about the things that went well. Next, the patient is advised 
to start doing enjoyable things in life. Finally a summary is given of the principles 
that the manual is based upon as well as tips on how to deal with anxiety in the 
future. 
Assessment of progress 
Table 1 shows the patients’ scores on the questionnaires and the effect size of the 5 
patients taken together. The effect size Cohen’s d (Cohen, 1988) is calculated by 
dividing the difference of pretest and posttest by the mean standard deviation. The 
effect sizes indicated a large treatment effect on all measures. 
In addition, the progress of the sample was expressed by the clinical significance of 
improvement (Jacobson & Truax, 1991). To fulfil this criterion: (i) a reliable change 







must have been taken place, and (ii) the posttest score must meet the criterion for 
‘recovered’. Of the measurements used in this pilot study, we chose the GHQ-12 
and the FQ subscales ‘total phobia’ and ‘anxiety/depression’ to demonstrate a 
‘reliable change’ for each patient separately. The GHQ-12 is an instrument much 
used in primary care research in anxiety and depressive problems and the FQ is 
very sensitive for change in anxiety problems. From table 2 it follows that 2 
patients could be considered recovered when measured with the GHQ-12 and the 
FQ anxiety/depression subscale and 4 with the FQ total phobia subscale. The 
patients 2 and 3 were considered ecovered on all three measurement instruments. 
 
Table 1: Outcome measures at pretest and posttest 





Sex► F M F F F Mean (SD) Effect 
size 
Patient number► 1 2 3 4 5  (d) 
Questionnaire▼  
   GHQ-12   
      Pretest 1 10 12 7 0 6(5,34) 1,35 
      Posttest 0 2 0 4 0 1,2(1,79)  
   FQ total phobia  
      Pretest 48 34 47 66 22 43,4(16,52) 2,36 
      Posttest 20 14 13 26 14 17,4 (5,55)  
   FQ anxiety/ 
   depression 
 
      Pretest 15 36 29 18 16 22,8(9,26) 1,44 
      Posttest 11 10 5 22 10 11,6 (6,27)  
   STAI state  
      Pretest 53 52 55 41 52 50,6(5.5) 1,26 
      Posttest 48 46 46 31 43 42,8(6,8)  
   LWASQ  
      Pretest 98 106 130 136 97 113,4(18,35) 2,52 
      Posttest 63 73 59 96 69 72(14,46)  
PD=panic disorder. GAD=generalized anxiety disorder. F=female. M=male. SD=standard deviation. LWASQ=Lehrer-Woolfolk 
Anxiety Symptom Questionnaire. STAI=Spielberger State-Trait Anxiety Inventory. FQ=fear questionnaire. GHQ=general health 
questionnaire. 
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All but one patient spent the advised time in doing their homework. The mean 
time spent by the patient at home was 2 hours and 48 minutes a week. The mean 
time spent per session by the therapist was 23 minutes. 
Patient 1 has been seen six times in 16 weeks. After 7 weeks she felt very restless 
and could not concentrate. She worried about her father. She was used to care for 
others, especially her father, and had difficulties taking care of herself. She thought 
she was not capable to participate in the treatment well enough, so she decided to 
stop to work with the manual before the fourth session. In this session the therapist 
convinced her to continue, and she started again with the manual. The therapist 
gave her the opportunity to call between appointments when things did not work 
out well. She did not have the need to use this possibility. After 12 weeks (the fifth 
session) she felt much better, and did not have panic attacks anymore. She made a 
start with the exposure in vivo exercises and asked for an extra session four weeks 
later. During this period, in which she exercised a lot, she improved most. She gave 
herself a present to celebrate her successes. In the course of these 16 weeks, her 
self-confidence improved and she regained freedom of movement she had missed 
due to her fears. The agoraphobic avoidance behaviour was almost completely 
disappeared and she worries no longer about illnesses or accidents anymore. In 
general, her anxiety was diminished and she had less physical complaints such as 
palpitations or breathlessness. She felt no longer obliged to hide her feelings for 
other people. The depressive complaints diminished as well and she planned to go 
to her GP to taper down her clomipramine. The questionnaires showed a marked 
improvement of complaints. She did not meet the criteria for an anxiety disorder 
anymore. Especially on the phobia scale her complaints almost completely 
disappeared. 
Patient 2 was seen five times in the scheduled 12 weeks. During treatment using 
the self-help manual and relaxation exercises his physical complaints diminished. 
He reported that he understood more about his anxiety, which gave him 
reassurance. The relaxation exercises helped him to feel less tense, while the 
exposure exercises helped him doing more what he wanted. The avoidance 
behaviour decreased, as did many depressive symptoms. For this patient one 
meeting every four weeks was not enough to continue the self-help treatment. He 
decided he needed more intensive treatment and planned to visit his general 
practitioner for a referral to a psychotherapist. 
Patient 3 had 5 appointments from which it appeared that she spent quite a lot of 
time on her homework. Especially, she carried out the exposure tasks very well. 
For example, she had a vacation to Spain for 3 weeks after 6 weeks of treatment. 







When she returned she reported she could travel by airplane without fear and had 
a nice and busy time. The panic attacks had not disappeared, but she could 
understand them better and accept them with less fear. 
Patient 4 From the scheduled five sessions it appeared that she tried to do her 
homework well. However, she had difficulties with fully understanding the self-
help manual. This was discussed during the sessions. She was able to carry out the 
relaxation exercises without problems. She had asked her daughter to help her 
with the exercises. In the last weeks of the treatment her daughter was absent and 
she stopped the exposure sessions. She mainly did the relaxation exercises, which 
helped somewhat. After 12 weeks, when her daughter was present again, she 
decided to continue the use of the manual. As table 2 shows, she markedly 
improved and fully recovered on the phobia scale of the FQ. Her depressive 
complaints remained. There was no improvement on the anxiety/depression scale 
of the FQ. She improved on the GHQ, which means that she felt better in life now 
then prior to the treatment. Her physical complaints and worries decreased. 
Patient 5 was seen four times in the 12-week period. She did not have any panic 
attacks during treatment and explained that she benefited most from the tape with 
relaxation exercises. She did not want to confront her hypochondriacal fears by 
reading about cancer or watching medical programs, because in her opinion her 
complaints were not that troublesome at that moment. This fits with her rather low 
pretest scores (see table 2). As expected she decided not to continue using the 
manual afterwards. 
 












Improved Recovered Improved Recovered Improved Recovered 
1 N N Y Y N N 
2 Y Y Y Y Y Y 
3 Y Y Y Y Y Y 
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The feasibility and effectiveness of the self-help manual for general practice 
patients with anxiety disorders appeared to be excellent. Only few complicating 
factors occurred during treatment. As the complaints of patient five were not very 
pronounced during the twelve weeks of treatment, she decided not to do the 
exposure exercises. Patient four became more anxious while reading the manual. 
In the opinion of patient two, the guidance was insufficient. Patients 2 and 3 chose 
not to find a helper, because they were ashamed of having a mental disorder. 
These patients followed the manual on their own. In order to profit from the 
treatment all patients had to do much homework. This means that they must be 
well motivated to work on their problems. Sometimes this did not succeed (patient 
5). For some patients (2 and 4) the 12 weeks of treatment was too short to profit 
sufficiently. They went on with psychotherapy after finishing the self-help manual.  
An important weakness of this study is that the first author was the only therapist. 
She was quite familiar with the treatment of anxiety disorders and enthusiastic 
about this form of treatment. We can not rule out that her competence and her 
enthusiasm have influenced the effectiveness of this self-help manual in a positive 
way. Further testing of the self-help manual in general practitioners is needed to 
allow more definitive conclusions of its effectiveness. 
Managed care considerations 
The results of this pilot study suggest that a guided self-help manual treatment for 
PD and/or GAD is an effective treatment option in primary care. The therapist 
support of the manual involved 5 sessions of about 20 minutes, making it feasible 
in general practice as well. Most patients achieved a clinically relevant 
improvement. When these results can be confirmed in a controlled trial in a larger 
sample, guided self-help treatment may evolve into a very relevant option in 
general practice as part of a stepped care approach of PD and GAD. The GP should 
consider self-help format as an option for patients presenting with problems of PD 
or GAD in primary care, especially when they have preference to learn to their 
problems and not to choose directly for medication. In addition, it must be taken 
into account that patients are good candidates for treatment with the manual when 
they are motivated to work by their selves on these problems. In these cases self-
help treatment with guidance is a valuable option to consider before starting 
medication or referring the patient to secondary care. 








We do not have follow-up data of these patients. Since the anxiety disorders run a 
chronic course, long-term effectiveness of a treatment is even more important than 
its short-term effectiveness. A study on the long-term improvement in a larger 
sample is being conducted. 
Treatment implications of the cases 
These cases are examples of the effectiveness of guided self-help treatment in 
primary care patients with relatively severe long-standing panic disorder or GAD. 
However, for patients with PD the manual was more effective than for patients 
with GAD. This may be due to the fact that in the evaluated self-help manual no 
attention was paid to the change of meta-worries, frequently present in GAD 
(Wells, 1999). 
Our treatment results may be influenced by the fact that all patients included were 
motivated to participate, shown by the fact that they were willing to travel to an 
outpatient clinic for a diagnostic interview and receive treatment with the self-help 
manual. In addition, the therapist (first author) was highly motivated as well to 
succeed in this treatment, and enhancing treatment effect of the manual. Until now 
there are a number of controlled studies which support the use of self-help manual 
for the treatment of PD, but there is less evidence for the usefulness of self-help 
treatment in the treatment of GAD (Milne & Covitz, 1988; Donnan et al, 1990; 
Sorby et al, 1991; White, 1995; Kupshik & Fisher, 1999). 
The effect sizes for improvement on the anxiety measures were large and higher 
than reported before. Other studies with self-help manuals in primary care patients 
demonstrated heterogeneous effect sizes between –0.18 and 0.99 on anxiety 
symptoms (Milne & Covitz, 1988; Donnan et al, 1990; Sorby et al 1991; White, 1995; 
Kupshik & Fisher, 1999). Perhaps the difference in the magnitude of these effect 
sizes is to be explained by the time spent on the treatment manual by patients and 
therapist. In comparison with other studies more time was spent by therapist and 
patient to the self-help manual. Another important difference with the above-
mentioned studies is that our study was not a randomized controlled study. All 
patients were directly referred to the self-help manual treatment by the GP. Due to 
this selection it may be possible that only highly motivated patients were included. 







Recommendations to clinicians and students 
In an environment of limited resources it makes sense to provide all the time and 
attention a patient needs, but not more. If spontaneous recovery does not occur in 
PD and GAD patients in primary care, a minimal intervention in the form of a self-
help treatment can be offered. Especially when patients prefer psychological 
instead of pharmacological treatment for their anxiety symptoms this self-help 
manual treatment may be an alternative to referral to secondary care. In a recent 
study with depressed primary care patients it was demonstrated that a substantial 
percentage of patients preferred psychotherapy over pharmacological treatment. 
Patients with strong preferences, mostly for psychotherapy, are likely not to enter 
antidepressant treatment or randomized clinical trials if their preferences are not 
supported (van Schaik et al, 2004) Evidently, the use of self-help material has clear 
advantages. Although this preferences for psychotherapy has never been 
demonstrated in the treatment of anxiety disorders it is plausible that such 
preferences also exist in other common mental disorders.  
Increased cost-effectiveness can make an effective treatment accessible to more 
patients in need of assistance. However, patients must be able and willing to spend 
time to their homework in order to be able to profit from the treatment offered. The 
results of this pilot study may fit in a stepped care approach and suggest that 
guided self-help treatment may be a first line treatment of PD and to a lesser extent 
GAD in general practice. 
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Anxiety disorders are prevalent in primary care. Psychological treatment is 
effective but time–consuming, and there are waiting lists for secondary care. 
Interest has therefore grown in developing guidelines for treatment that would be 
feasible in primary care. 
Aim 
To compare the effectiveness and feasibility of guided self-help, the Anxiety 
Disorder Guidelines of the Dutch College of General Practitioners and cognitive 
behavioural therapy (CBT). 
Design of study 
Randomised controlled study lasting 12 weeks with follow-up at 3 and 9 months 
for primary care patients with panic disorder and/or generalized anxiety disorder. 
 








The first two forms of treatment were carried out by 46 general practitioners (GPs) 
who were randomly assigned to one or the other form. CBT was carried out by 
cognitive behaviour therapists in a psychiatric outpatient clinic. 
Methods 
Participants (n=154) were randomly assigned to one of the three forms of 
treatment. The main outcome measure used was the state subscale of the 
Spielberger Anxiety Inventory. 
Results 
All three forms of treatment gave significant improvement between pretest and 
posttest, and this improvement remained stable between posttest and the follow-
ups. The results obtained with the three treatment forms did not differ significantly 
over time. The feasibility of the Anxiety Disorder Guidelines was low compared 
with that of guided self-help. 
Conclusions 
Our results indicate that primary care patients with prevalent anxiety disorders for 
whom the GP does not find referral necessary can be adequately treated by the GP. 
Referral to psychiatric outpatient clinic does not give superior results. Guided self-
help is easier for the GP to carry out than a less highly structured treatment like 
that laid down in the Anxiety Disorder Guidelines. 
Keywords 
Generalized anxiety disorder, panic disorder, randomised controlled trial, primary 
















The World Health Organisation study on psychological problems in general health 
care demonstrated a 10.1% prevalence rate for anxiety disorders (Ormel et al, 
1994). As a consequence, general practitioners (GPs) often see these disorders in 
their patients. The most common forms are panic disorder with or without 
agoraphobia and generalized anxiety disorder (Bijl et al, 1997). GPs often treat 
anxiety disorders with antidepressants or benzodiazepines. These drugs are 
effective but have several disadvantages including the risk of dependency, side-
effects and poor patient compliance. Furthermore, anxiety symptoms often recur 
when the drugs are discontinued (Rickels & Rynn, 2002; Simon et al, 2002). These 
disadvantages are irrelevant in treatment programs based upon cognitive and 
behavioural principles¬. However, such programs are usually not suitable for 
primary care because they are time-consuming and require extensive training of 
the therapist. Most research into the efficacy of cognitive behavioural therapy 
(CBT) has taken place in secondary care settings (van Balkom et al, 1997; Bakker et 
al, 1998; Gorman, 2002).  
In order to stimulate the use of simple cognitive behavioural techniques in primary 
care, the Dutch College of General Practitioners recently developed guidelines for 
the treatment of anxiety disorders. The efficacy and feasibility of these guidelines 
have not yet been evaluated (Terluin et al, 2004). 
Another development in the treatment of anxiety disorders in primary care is the 
use of self-help manuals based on cognitive behavioural techniques. Self-help 
treatment appears to be effective in both the short and the long term (Bond & 
Dryden, 2002). However, the interpretation of these results has so far been 
hampered by small patient samples and the failure to use appropriate diagnostic 
criteria for the anxiety disorders studied (Bower et al, 2001; van Boeijen et al, 2005). 
In addition, the effectiveness of self-help manuals for anxiety disorders in primary 
care has not been compared with that of CBT in secondary care, which may be 
considered the gold standard in this field. 
The purpose of this study is to compare the effectiveness and feasibility of a self-
help manual for anxiety disorders used by the patient under the direction of the 
GP (referred to from now on as Manual) with CBT carried out by experienced 
cognitive behaviour therapists in secondary care. These two forms of treatment 
were further compared with the Anxiety Disorders Guidelines of the Dutch 
College of General Practitioners (referred to henceforth as Guidelines). Since the 
three treatments differed mainly in the intensity and complexity of the cognitive 







behaviour techniques used, we hypothesised that the most intensive form (CBT in 
secondary care) would give the best results, followed by Manual and with 
Guidelines as a significantly poorer third. 
Methods 
Design 
The effectiveness of the three treatments for panic disorder and generalized 
anxiety disorder was compared in a 12-week study with a 12-week treatment-free 
follow-up period. After that the patients were given conventional treatment 
tailored to their needs. Follow-up 1 was scheduled 24 weeks after pretest, and 
follow-up 2 was 52 weeks after pretest. The patients were randomly assigned to the 
three forms of treatment: (i) use of the Manual under the guidance of the GP, (ii) 
CBT, given in a psychiatric outpatient clinic by experienced cognitive behavioural 
therapists, and (iii) Guidelines implemented by the GP. The study was approved 
by the Medical Ethics committee of the VU University Medical Centre and was 
performed from February 1998 to May 2002. 
Subjects and recruitment 
The participants, all over 18 years of age, were recruited from 46 general practices 
in rural and urban areas of the Netherlands. GPs identified possible panic disorder 
or generalized anxiety disorder with the aid of the Short and Simple Screening 
interview (SSI, Goldberg et al, 1988). If the SSI score was 5 or more, participants 
were invited for a diagnostic interview using the Structured Clinical Interview 
technique described in DSM-IV (the 4th edition of the Diagnostic and Statistical 
Manual of Mental Disorders, SCID-IV, First et al,1997). The participants were 
asked to participate in the study when the results of this interview showed that 
they met the criteria for panic disorder or generalized anxiety disorder. Exclusion 
criteria were the presence of an organic mental disorder; mental retardation or a 
psychotic disorder; treatment of anxiety disorders in the recent past; use of 
antidepressants or the use of more than 30mg oxazepam equivalents daily. After a 
full explanation of the study procedures, participants gave written informed 
consent. 
Sample size and randomisation 
The participating practices (n=46) were first randomly assigned in a ratio of 1:1 to 
Manual or Guidelines as primary care method (van der Feltz & Adèr, 2000). Next, 







within each practice, patients were randomly assigned to primary or secondary 
care in a ratio of 2:1. For both randomisations a computerised randomisation 
scheme was used. In both randomisation procedures (primary care practices and 
participants) the assignments were put in sequentially numbered sealed, opaque 
envelopes by an independent statistician. At the start of the study the first author 
opened the envelopes for the participating practices. During the study the first 
author opened the envelopes after participants had given their informed consent.  
Our aim was to find a medium effect size (corresponding with a 5.5 point 
difference) on the state subscale of the Spielberger State-Trait Anxiety Inventory 
(STAI) between the treatment conditions. This effect size required a sample size 
(alpha = 0.05; two sided beta = 0.20) of 50 participants in each group. This 
estimated effect size was corrected for the difference between the two follow-up 
measurements (within-person correlation assumed to be 0.7) and the variation 
within GP groups (within-GP correlation assumed to be 0.2), using an assumed 
standard deviation of 10 (Diggle et al, 1994; Goldstein, 1995). 
It was found during the study that the practices randomly assigned to Manual had 
on average twice as many patients as those assigned to Guidelines. As a 
consequence, there was an unintended difference in size between the three study 
groups. Having consulted an independent statistician, the authors therefore 
decided halfway through the study to change the primary care : secondary care 
randomisation ratio in the practices offering Manual from 2:1 to 1:2. Since this 
change could yield biased results because the equivalence of the treatment and 
control groups is relaxed, we analysed post-hoc whether the differences in 
inclusion and outcome before and after the change in the randomisation ratio 
critically affected our results. This did not appear to be the case. We did not find 
significant pretest differences in demographic and clinical status variables, nor 
posttest differences in outcome. 
Treatment 
All participants received individual treatment for 12 weeks based on cognitive-
behavioural principles. The three treatments differed mainly in intensity and 
complexity. GPs and therapists received relevant training. The GPs were present at 
two educational meetings on diagnosis and treatment of anxiety disorders. 
Supervision was provided by the first three authors every 2 months during the 
study. The cognitive behavioural therapists, all with extensive experience in the 
treatment of anxiety disorders received weekly supervision of the fourth author. 







Self-help treatment consisted of five 20–minute sessions. In the first session, the GP 
informed the participant about the contents of the manual, which comprised an 
explanation of the basic facts about anxiety, simple cognitive techniques, and 
relaxation and in vivo exposure exercises. The participants put the self-help 
techniques learnt from the manual into practice for 3 hours a week. In subsequent 
sessions, the GP reinforced the patient’s achievements and motivated him or her to 
continue with the use of the manual (van Boeijen et al, in press 2006). 
CBT comprised twelve 45-minute sessions. The participants practiced for 3 hours a 
week. They received a CBT handbook explaining the basic facts about anxiety and 
the rationale of CBT, identifying anxiety-provoking cognitions and showing the 
patient how he or she can challenge these cognitions by means of a Socratic 
dialogue and replace them by more realistic and rational cognitions. The credibility 
of catastrophic cognitions was tested with the aid of behavioural experiments, and 
in vivo exposure exercises were given (Öst, 1987; Clark, 1989; Wells, 1997). 
Guidelines was the least structured form of treatment, and consisted of a very 
simple form of CBT. The GP was free to choose the number of sessions and the 
type of intervention, but was advised to start with explanation about the nature of 
anxiety followed by reassurance, simple cognitive techniques and in vivo 
exposure. The GP was allowed to refer the patient for relaxation exercises or 
psychiatric treatment and to prescribe antidepressants or benzodiazepines (Terluin 
et al, 2004). 
Measurements 
Participants filled out questionnaires at four points in time during the study, to 
provide a measure of the presence and severity of psychopathological symptoms 
associated with panic disorder or generalized anxiety disorder: pretest 
(immediately after informed consent had been given), posttest after 12 weeks, 
follow-up 1 after 24 weeks and follow-up 2 after 52 weeks.  
Since the severity of anxiety is the psychopathological parameter most widely used 
in the diagnosis of panic disorder and generalized anxiety disorder, the state 
subscale of the STAI was used to determine the primary outcome measure 
(Spielberger et al, 1970). The following secondary outcome measures were: the trait 
subscale of the STAI and the Lehrer-Woolfolk Anxiety Symptom Questionnaire 
(LWASQ, Lehrer & Woolfolk, 1982) as measures of Anxiety; the Penn State Worry 
Questionnaire (Meyer et al, 1990) as a measure of Worry; the Bodily Sensations 
Questionnaire and the Agoraphobic Cognitions Questionnaire (Chambless et al, 
1984) as measures of Panic; the agoraphobia scale of the Fear Questionnaire (Marks 







& Mathews, 1979) as a measure of Avoidance; the Beck Depression Inventory (Beck 
et al, 1961); the General Health Questionnaire-12 (Goldberg& Williams, 1988); and 
the Sheehan Disability Scale (Sheehan, 1983) as a measure of Social adjustment. 
Statistical analysis 
The three treatments were compared at pretest for differences in demographic and 
psychiatric status variables. Outcome analyses were performed on an intent-to-
treat basis. If an outcome value was missing, the pretest value was used to replace 
the posttest, follow-up 1 or follow-up 2 value. The analyses were repeated after 
excluding the dropouts. 
Primary and secondary outcome measures were subjected to analysis of variance 
(ANOVA) using the General Linear Model with 3 x 2 repeated measures, with the 
3 groups as between-subjects factor and the 2 evaluations (pretest and posttest) as 
within-subjects factor. The between-subjects factor was further broken down into 
two Helmert contrasts. The first contrast compared the mean change from pretest 
to posttest scores for CBT and Manual with that for Guidelines. The second 
contrast compared the mean change from pretest to posttest scores for CBT with 
that for Manual. These analyses were repeated on the mean change from pretest to 
follow-up 1 and from pretest to follow-up 2. Significant time effects for the primary 
and the secondary outcome measures were further analysed by means of paired t-
tests (pretest versus posttest; pretest versus follow-up 1 and pretest versus follow-
up 2 ) for each group separately. All statistical tests were two-tailed at alpha = 0.05, 
unless multiple test were performed in which case alpha was divided by the 
number of tests (Bonferroni correction) Data analysis were conducted using SPSS 
11.0 (SPSS Inc, Chicago, IL). 
Results 
Recruitment and attrition 
Figure 1 shows the variation of the total trial population during the study and the 
reasons for dropping out. Completers and dropouts were evenly distributed over 
the three treatment groups (p>0.67). 
Characteristics of the participants 
Pretest demographic characteristics and psychiatric status variables of the study 
sample are presented in Tables 1 and 2. No statistical differences were found 







between the various treatment groups, and no significant differences were found 
between dropouts and completers at pretest. 
 
Table 1: Pretest demographic characteristics of the study group 
Treatment type  

















Sex, male (%) 20 (38) 25 (40) 8 (31) 
Mean age (SD) 38.8 (12.7) 38.0 (12.5) 38.8 (13.3) 
Married  25 (47) 24 (38) 11 (42) 
Employed  30 (57) 38 (60) 18 (69) 
Higher education (%) 13 (25) 29 (46) 10 (38) 
Main diagnosis 
Panic disorder (%) 
Panic disorder and agoraphobia (%) 
Generalised anxiety disorder (%) 
















Mean duration in years of anxiety disorder 
(SD) 10.02 (13.21) 8.65 (11.54) 6.38 (9.17) 
GAD = generalised anxiety disorder. Guidelines = anxiety disorder guidelines by the Dutch College of General Practitioners. 
Manual = guided self-help treatment. PD = panic disorder. SD = standard deviation. Note: No significant differences emerged 
between the three conditions. 
 
Outcomes 
In the intent-to-treat sample, application of Helmert contrasts to the STAI state 
scores did not reveal significant differences between the two test points (pretest 
versus posttest; pretest versus follow-up 1; and pretest versus follow-up 2) or 
between the CBT and Manual treatments on the one hand and Guidelines on the 
other (between pretest and follow-up 2: effect size 0.06; 95% CI –5.3 – 2.5). No 
significant differences were found between CBT and Manual either (between 
pretest and follow-up 2: effect size 0.03; 95% CI –4.2 – 6.3). The same held for the 
analyses of the completer sample. Helmert contrasts yielded the same pattern of 
results for the secondary outcome measures (data not shown, the complete data 
can be obtained from the corresponding author). The three groups all improved 
significantly from pretest to posttest, pretest to follow-up 1 and pretest to follow-
up 2 on all outcome measures. No significant differences were found between 
posttest and follow-up 1 or follow-up 2. 







GPs’ views on the feasibility of self-help (Manual) and Guidelines 
treatment 
GPs randomly assigned to the Manual treatment group were much more active in 
putting participants forward for the study than those assigned to Guidelines. 
Although 23 GPs participated in both treatment groups, 17 in the Guidelines group 
put forward a total of 88 possible participants while 19 GPs assigned to the Manual 
group put forward a total of 199 participants. All GPs were interviewed to identify 
the disincentive factors that were operative here. Most GPs stated that they felt 
unable to carry out even the simplified CBT laid down in the Guidelines, and that 
the time investment needed was too high. As a result, half of the participants were 
treated with antidepressants, and one third were referred to secondary care. The 
mean number of visits to the GPs in the 12-week treatment period was 5.4 (SD 3.3). 
Discussion 
Summary of main findings 
It may be concluded that panic disorder and generalized anxiety disorder can be 
effectively treated in primary care by a GP using the Guidelines or Manual method 
and by experienced cognitive-behaviour therapists in secondary care. We could not 
confirm our hypothesis that the effectiveness of the treatments was directly related 
to the complexity and intensity of the form of CBT given. The three treatments did 
not differ significantly in reducing anxiety and associated symptoms. The major 
part of the improvement was realised in the first 12 weeks of the study. The GPs in 
the Guidelines group referred less than half as many participants to the study than 
the GPs in the Manual group, since they knew there was a chance that their 
patients would be assigned to the Guidelines treatment which they would have to 
deliver. The feasibility of Guidelines was rather low, because the GPs concerned 
felt incapable of delivering it or found it too time-consuming. It appeared that 
about half of the patients did not actually receive the intended CBT. Instead, they 
were treated with antidepressants and/or referred to secondary care. The gold 
standard, CBT in secondary care carried out by experienced therapists, was 
however not superior to the treatments carried out by GPs. Apparently primary 
care patients with anxiety disorders, whose GP does not consider referral to 
secondary care necessary, can receive optimal care from their GP. A more intensive 
secondary care treatment does not improve the outcome. 







Strengths and limitations of the study 
The results of this study suggest that Manual may be a feasible and effective 
treatment for panic disorder and generalized anxiety disorder in primary care. The 
effectiveness of Manual was comparable to that of the gold standard, CBT 
performed by professionals in secondary care. The improvement brought about by 
Manual treatment was maintained during 40 weeks of follow-up. Our results can 
be generalized to primary care patients with panic disorder and generalized 
anxiety disorder. Case finding in this study was performed by the GP during 
normal practice, instead of screening general practice patients in the waiting room. 
Moreover, the anxiety disorders in this study were diagnosed in a valid way by 
means of a structural interview. 
A limitation of our study was the low feasibility found for Guidelines. As a 
consequence the sample size in this group only reached half the size originally 
intended. Therefore, it is difficult to draw definite conclusions about this 
intervention. We do not think, however, that the inclusion of only 26 participants 
from this group in the study population has led to a type II error (failure to reject a 
false null hypothesis). Inspection of the data and the confidence intervals did not 
reveal any differences between the three treatment groups which might have 
become significant if the sample size had been larger. To avoid further divergence 
of the size of the cells, we decided halfway through the study to change the 
randomisation ratio in practices randomly assigned to the Manual treatment 
group. We cannot rule out the possibility that this change in the randomisation 
ratio has biased our results. However, such bias seems unlikely since no 
differences were found in post-hoc statistical analyses before and after this 
intervention. 
Comparison with existing literature 
The finding that CBT in secondary care was not superior to Manual was rather 
unexpected. Our study is the first in which these two treatments were compared in 
a single trial. The lack of difference found between CBT and Manual might be due 
to the fact that participants in both groups were given an equal number of hours of 
homework, or to the fact that the patients treated are taken from primary care, i.e. 
will on average only have relatively mild complaints for which formal CBT may 
represent ‘over-treatment’. Another unexpected finding was the effectiveness of 
Guidelines. However, more than half of the patients assigned to this treatment 
group did not in fact receive this simple form of CBT but were given 
antidepressants or referred to secondary care. While Guidelines may be suitable for 
motivated GPs, it seems that in the Netherlands most GPs do not have the affinity 







with or knowledge of this approach - or the time - to give even simple CBT 
exercises to their anxiety disorder patients. 
Implications for clinical practice 
Our results indicate that primary care patients with panic disorder and generalized 
anxiety disorder may be treated effectively by the GP and that referral to 
psychiatric outpatient clinic does not yield better results. Moreover, Manual is 
easier to carry out by a GP than a less structured treatment such as Guidelines, and 
results in fewer referrals to specialised care. 
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Figure 1: Recruitment to analysis 
 
CBT = cognitive behaviour therapy. ITT = Intention-to-treat 
Intake session SCID DSM IV
Assessed for eligibility n=229 
Manual (n=157) Guidelines (n=72) 
Randomisation n=45Randomisation n=109
Lost to follow-up 1 (n=3),
not reached in time for follow-up 1 
n=2 
and refused to fill out follow-up 1 
questionnaires n=1 











not meeting inclusion criteria 
(n=25) 
refused to participate (n=2) 
Informed consent n=154
Excluded n=48 
not meeting inclusion criteria 
(n=45) 
refused to participate (n=3) 
Allocated to Guidelines n=28 
Received Guidelines (n=28) 
Did not receive Guidelines (n=0) 
Did not fill out the pretest n=2  
Allocated to Manual n=59 
Received Manual (n=58) 
Did not receive Manual 
(n=1), refused treatment 
Did not fill out the pretest n=5  
Allocated to CBT n=67
(GP: Manual n=50, Guidelines n=17) 
Received CBT (n=63) 
Did not receive CBT (n=4), 
misdiagnosis PTSD n=1 and refused 
treatment n=3 
Did not fill out the pretest n=4 
Lost to follow-up 1 (n=7),
not reached in time for follow-up 1 
n=3 
and refused to fill out follow-up 1 
questionnaires n=4 
Analysed completers n=47 
Analysed ITT n=63 
Lost to follow-up 1 (n=8), 
not reached in time for follow-up 1 
n=3 
and refused to fill out follow-up 1 
questionnaires n=5 
Analysed completers n=21
Analysed ITT n=26 
Analysed completers n=39
Analysed ITT n=53 
Lost to posttest (n=2),
patient moved n=1 and refused to fill 
out posttest questionnaires n=1 
Refused to receive treatment (n=0) 
Lost to posttest (n=7),
not reached in time for posttest n=5 
and refused to fill out posttest 
questionnaires n=2 
Refused to receive treatment (n=2) 
Analysed completers n=54 
Analysed ITT n=63 
(GP: Manual n=47, Guidelines n=16) 
Lost to posttest (n=3), 
not reached in time for posttest 
Refused to receive treatment (n=3) 
Analysed completers n=24
Analysed ITT n=26 
Analysed completers n=47
Analysed ITT n=53 
Lost to follow-up 2 (n=4) Lost to follow-up 2  (n=7) Lost to follow-up 2  (n=0)
Analysed completers n=35
Analysed ITT n=53 
Analysed completers n=40 
Analysed ITT n=63 
Analysed completers n=21
Analysed ITT n=26 







Table 2: Pretest, posttest, follow-up 1 and follow-up 2 clinical characteristics of study group (intention-to-treat 
sample) 
  Treatment type 
  Manual 
(n=53) 




Scales range Mean SD  Mean SD  Mean SD 
Anxiety          
STAI State 20-80         
pretest  52.0 13.7  47.7 12.7  52.6 12.0 
posttest  47.0 13.6  41.3 12.4  40.5 9.8 
follow-up 1  44.3 12.5  40.6 13.0  42.9 10.5 
follow-up 2  42.9 12.8  40.6 14.2  38.8 11.5 
STAI Trait 20-80         
pretest  55.5 8.8  51.2 11.7  55.8 8.2 
posttest  48.9 11.9  45.3 12.1  46.8 9.6 
follow-up 1  46.6 12.0  43.0 13.2  45.3 11.9 
follow-up 2  44.6 11.8  42.7 13.2  41.3 10.6 
LWASQ Somatic  16-80         
pretest  45.5 11.6  39.3 13.0  41.8 11.6 
posttest  36.6 12.3  32.6 13.4  33.8 11.7 
follow-up 1  34.6 12.1  31.1 13.4  31.2 12.2 
follow-up 2  33.7 11.7  31.9 15.0  29.7 12.2 
LWASQ Behaviour 9-45         
pretest  20.4 8.2  19.6 7.9  19.7 7.1 
posttest  18.0 7.5  17.8 7.6  17.4 5.6 
follow-up 1  16.8 6.6  17.2 7.4  16.3 5.0 
follow-up 2  16.5 7.6  17.6 8.6  14.4 5.8 
LWASQ Cognition 11-55         
pretest  33.7 9.2  30.2 9.0  31.2 8.7 
posttest  28.4 9.8  25.4 9.2  26.2 8.7 
follow-up 1  27.2 9.4  24.2 9.8  23.1 8.5 
follow-up 2  26.3 9.8  24.4 10.4  20.6 8.7 
Worry          
PSWQ 16-80         
Pretest  59.7 12.8  54.7 12.9  60.0 10.5 
Posttest  53.9 12.7  50.3 13.1  51.8 11.9 
follow-up 1  53.2 12.2  48.7 13.4  50.1 14.4 
follow-up 2  51.9 12.8  47.5 12.9  46.6 11.7 
Panic          
BSQ 1 17-85         
pretest  42.8 15.3  38.5 13.4  43.5 11.0 
posttest  36.1 13.0  32.4 11.9  36.4 13.1 
follow-up 1  35.7 13.7  31.9 13.0  36.5 15.2 
follow-up 2  34.1 13.1  32.6 14.9  33.5 14.0 
BSQ2 17-85         
pretest  43.7 10.4  42.5 12.0  43.3 9.6 
posttest  38.0 10.6  37.3 12.6  38.5 11.8 
follow-up 1  36.3 11.4  34.7 11.8  35.9 11.3 
follow-up 2  35.5 11.8  34.8 13.4  32.6 10.4 
ACQ 14-70         
pretest  28.6 9.9  28.1 10.1  28.6 10.9 
posttest  25.1 9.3  24.4 8.9  24.7 9.2 
follow-up 1  23.9 8.6  23.2 9.3  23.7 9.8 
follow-up 2  23.6 9.3  22.7 9.5  21.1 6.9 
Table 2 continues on the next page… 
 








Table 2 continued 
  Treatment type 
  Manual 
(n=53) 




Scales range Mean SD  Mean SD  Mean SD 
Avoidance          
FQ Agoraphobia 0-40         
pretest  12.8* 11.6  10.6 10.4  14.0 11.4 
posttest  11.2* 10.8  6.7 8.1  10.3 10.0 
follow-up 1  9.4 10.5  6.6 9.5  8.5 8.5 
follow-up 2  9.1 10.8  5.9 9.0  6.5 7.2 
Depression          
BDI 0-63         
Pretest  16.4 9.7  14.8 8.4  12.6 6.1 
Posttest  12.0 9.1  9.8 8.2  8.4 6.9 
follow-up 1  11.1 8.4  9.6 8.7  8.6 8.5 
follow-up 2  10.3 7.9  9.3 8.3  7.2 4.9 
General health          
GHQ-12 0-12         
Pretest  7.1 3.7  5.4 4.1  7.4 3.5 
Posttest  3.8 4.3  2.4 3.2  3.0 4.0 
follow-up 1  3.4 4.0  2.3 3.4  2.8 3.7 
follow-up 2  3.2 3.9  2.4 3.4  2.1 3.2 
Disability          
SDS Work 0-10         
Pretest  6.1 3.0  5.5 3.0  5.7a 3.0 
Posttest  4.9 3.2  3.5 3.3  4.6b 2.6 
follow-up 1  4.1 3.3  3.1 3.3  3.8 3.0 
follow-up 2  3.6 3.2  3.2 3.4  2.9 2.8 
SDS Social/Leisure 0-10         
Pretest  6.6 2.4  5.2 2.7  6.5 2.3 
Posttest  4.8 3.3  3.3 2.9  4.8 3.0 
follow-up 1  4.3 3.0  3.1 2.9  4.4 2.9 
follow-up 2  3.8 2.8  3.0 3.0  3.4 2.7 
SDS Family/Home 0-10         
Pretest  6.0 2.4  4.6 3.0  5.3 2.8 
Posttest  3.6 3.0  2.9 2.9  3.0 2.5 
follow-up 1  3.7 3.0  2.6 3.0  3.5 3.0 
follow-up 2  3.3 3.2  2.6 3.1  2.9 2.6 
ACQ = Agoraphobic Cognitions Questionnaire. BDI = Beck Depression Inventory. BSQ = Body Sensation Questionnaire. FQ = 
Fear Questionnaire. GHQ = General Health Questionnaire. Guidelines = Anxiety Disorder Guidelines of the Dutch College of 
General Practitioners. LWASQ = Lehrer Woolfolk Anxiety Symptom Questionnaire. Manual = Guided Self-Help Treatment. 
PSWQ = Penn State Worry Questionnaire. SD = standard deviation. SDS = Sheehan Disability Scale. STAI = Spielberger State-
Trait Anxiety Inventory. No significant differences emerged between the pretest scores of the three conditions. aNo significant 
time effect (pre-posttest) in Manual condition for avoidance (FQ) p=.131. bNo significant time effect (pre-posttest) in 
Guidelines condition for SDS work p=.066. Note: for all other measurements significant time effect (pre-posttest; pre-follow-
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Comorbid depression but not comorbid anxiety disorders 
predict poor outcome in anxiety disorders 
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To study the influence of type of comorbidity on the 1-year course of a sample of 
141 outpatients with panic disorder with or without agoraphobia and generalized 
anxiety disorder receiving different forms of cognitive behaviour therapy. 
Methods 
Influence of type of comorbidity was determined on change scores (linear 
regression analysis) and remission data (Kaplan-Meier survival analysis). Three 
categories as assessed at pretest were compared: no comorbidity, comorbidity 
among anxiety disorders and comorbidity with mood disorders. Primary outcome 
variable: State-Trait Anxiety Inventory State subscale measured at four 
assessments (0, 12, 24 and 52 weeks). 
 








Analyses on change and on remission indicated that comorbidity with mood 
disorders led to (i) less improvement and (ii) a smaller remission rate than 
comorbidity among anxiety disorders and no comorbidity. No significant 
difference emerged between the ‘no comorbidity’ group and the ‘comorbidity 
among anxiety disorders’ group.  
Conclusions 
Because comorbidity critically influences prognosis, it appears to be important to 
reliably diagnose the disorders present. In patients with anxiety disorder and 
comorbid mood disorders cognitive behavioural therapy may be not the first 
choice treatment. 
Keywords 
Anxiety disorders, depression, comorbidity, cognitive behavioural therapy, long-






















Recent studies into the patterns of comorbidity of anxiety disorders have revealed 
that comorbidity (i) among the anxiety disorders (Brown & Barlow, 1992; Bijl et al, 
1997; van Balkom et al, 2000) and (ii) between anxiety and mood disorders (Brown 
& Barlow, 1992; Bijl et al, 1997; van Balkom et al, 2000; Pirkola et al, 2005) is the rule 
rather than the exception. This finding has led to criticism of the present diagnostic 
system from European and Australian clinicians (Andrews, 1996; Tyrer et al, 2004; 
Maj, 2005), stating that so-called ‘comorbidity’ is a consequence of the splitting of 
the neurosis concept into several anxiety and mood disorders with the introduction 
of DSM-III in 1980 and the subsequent proliferation of the number of diagnostic 
categories in the next versions of the DSM system. Moreover, ‘comorbidity’ would 
be an artificial by-product of overlapping symptom patterns revealed with the use 
of standardised diagnostic interviews (Maj, 2005). However that may be, it has 
been found repeatedly that patients with comorbid anxiety and mood disorders 
have more severe complaints (Andrade et al, 1994; Grunhaus et al, 1994; Kessler et 
al, 1994; Brown et al, 1995; van Balkom et al, 2000), a higher utilisation of services 
(Kessler et al, 1994; Jacobi et al, 2004) and poorer outcome of treatment focussed on 
the anxiety disorder (Keijsers et al, 1994; Pollack et al, 1994; Corominas et al, 2002; 
Shankman, 2002).  
Surprisingly, the influence of comorbidity among the anxiety disorders on the 
course of the (index) anxiety disorder has received little attention. As far as we 
know, only one study has focussed on the differential influence of comorbidity 
among anxiety disorders vs. comorbidity between anxiety and mood disorders 
(Bruce et al, 2005). In this study with a clinical sample it was found that 
comorbidity of generalised anxiety disorder or depressive disorder negatively 
influenced recovery rates in patients with panic disorder with agoraphobia but not 
in panic disorder. Moreover, the effect of comorbid generalised anxiety disorder 
affected the course of social phobia negatively, in contrast to comorbid depressive 
disorder (Bruce et al, 2005). Unfortunately, this study did not take into account the 
number of diagnoses present. Thus, the debatable question remains whether it is 
the presence of comorbidity in itself (cf. the number of diagnoses), or rather 
specific comorbidity that negatively influences anxiety disorder treatment 
outcome. We were able to study this problem in a sample of patients with panic 
disorder and/or generalised anxiety disorder and psychiatric comorbidity treated 
with cognitive behavioural therapy in general practice or specialised secondary 
care.  









In a 12-week randomised controlled trial the effectiveness of three treatment 
modalities in panic disorder with or without agoraphobia (PA) or generalised 
anxiety disorder (GAD) was compared: (i) referral to secondary care for cognitive 
behavioural therapy (CBT) provided by experienced therapists versus treatment in 
primary care practice by the general practitioner (GP) with (ii) a guided self-help 
CBT manual for PA or GAD or (iii) treatment according to the anxiety disorder 
guidelines of the Dutch College of General Practitioners. Follow-up I was 
scheduled at 24 weeks after a treatment-free period while a naturalistic follow-up 
II was scheduled at 52 weeks. The study was approved by the Medical Ethics 
committee of the VU University Medical Centre, Amsterdam, The Netherlands, 
and was performed from February 1998 to May 2002. The results of the 
randomised controlled trial are reported elsewhere in detail and are therefore 
summarized only briefly here (Van Boeijen et al, 2005). 
Outcome 
Included were 141 participants over 18 years of age, recruited from general 
practices in rural and urban areas of the Netherlands, who met DSM-IV criteria for 
PA or GAD. To confirm the diagnosis and to determine the presence of comorbid 
diagnoses, participants were interviewed with the Structured Clinical Interview for 
DSM-IV (SCID-IV; First et al, 1997). Exclusion criteria were presence of an organic 
mental disorder; mental retardation or psychotic disorder; use of antidepressants 
or the use of more than 30mg oxazepam equivalents daily. 
All participants received individual 12-week treatment based on cognitive-
behavioural principles. The three treatment categories differed mainly in intensity 
and complexity. All treatments included psycho-education about anxiety and the 
rationale of CBT, identification of anxiety-provoking cognitions, challenging these 
cognitions and replacing them by more realistic and rational cognitions, 
behavioural experiments, relaxation techniques and in vivo exposure exercises 
(Emmelkamp et al, 1989). Specialised care with CBT was the most intensive 
treatment, comprising twelve 45-minute sessions and three hours homework per 
week. Treatment by the GP with the guided self-help manual consisted of five 20–
minute sessions (Van Boeijen et al, 2005; Van Boeijen et al, in press). Treatment 
according to the anxiety disorder guidelines was the least structured form of 
treatment, and consisted of a very simple form of CBT. The GP was free to choose 







the number of sessions and the type of intervention, but was advised to start with 
explanation about the nature of anxiety followed by reassurance, simple cognitive 
techniques and in vivo exposure. (Neomagus, 1997: updated Terluin et al, 2004) 
Participants filled out questionnaires at pretest, 12 weeks (posttest), 24 weeks 
(follow-up I) and 52 weeks (follow-up II). The state subscale of the Spielberger 
State Trait Anxiety Inventory (STAI-State; Spielberger et al, 1970) was the primary 
outcome measure. Outcome in the completer sample and intent to treat sample 
was identical: the three treatment categories gave significant and clinically relevant 
improvement between pretest and posttest. This improvement remained stable 
between posttest and follow-up I respectively follow-up II. The effectiveness of the 
three treatments did not differ significantly on any moment. Thus, for the present 
study, the results of the three treatment categories were lumped together. 
Participants 
Of the 141 participants included, two were excluded from the statistical analyses 
because of outlying pretest scores of more than 2 standard deviations from the 
mean on the STAI-State. Moreover, given the definition for remission used in this 
study, both patients almost could be considered ‘remitted’ at pretest. Both 
participants belonged to the group anxiety disorders with comorbid mood 
disorders (see further). One of these participants was diagnosed with 6 comorbid 
diagnoses and had a pretest score of 36 on the STAI-State. The second participant 
was diagnosed with 7 comorbid diagnoses and scored 35 on the STAI-State at 
pretest. 
To study the influence of comorbidity, participants were divided into three groups 
according to the diagnoses determined with the SCID at pretest: (i) no-comorbidity 
(n=65) including only participants diagnosed with PA (n=50) or GAD (n=15), (ii) 
comorbidity among anxiety disorders (n= 56), including all participants diagnosed 
with PA or GAD, at least one comorbid anxiety disorder and no comorbid mood 
disorder, and (iii) comorbidity with mood disorders (n=18), including those 
patients with at least one anxiety disorder and a comorbid depressive disorder 
(n=16), dysthymia (n=1), and depressive disorder with comorbid dysthymia (n=1). 
Remission  
Based on population scores, remission was defined as a score on the STAI-State 
lower than 34 (Van der Ploeg, 1980). This score is derived from validation studies 
of the STAI-State in the Netherlands with a population of healthy medical 
students. In rest, 96 healthy male students had a mean score of 34.3 (SD = 7.3) 







versus a mean score of 33.7 (SD = 6.7) in 59 females. Comparing these scores with 
STAI-state score under stress in healthy medical students of mean 43.3 (SD = 10.3) 
in males versus mean 45.1 (SD = 11.8) in females and anxiety disorder outpatients 
of 45.0 (SD = 10.2) in males and 51.8 (SD = 10.8) in females, it can be concluded that 
the definition of remission used was rather conservative.  
Statistical analysis 
The three groups were compared at pretest for differences in demographic and 
psychiatric status variables with one-way ANOVA or Chi square tests. Treatment 
effect on the STAI-State was analysed within each group with paired t-tests, 
comparing pretest with posttest, follow-up I or follow-up II. 
The influence of comorbidity on treatment outcome was analysed with (i) change 
scores and (ii) remission data. To delineate change in anxiety sores on the STAI-
State over time the ‘residual gain score’ was used as this score is more reliable 
compared with a ‘raw’ change score. Moreover, the residual change score corrects 
for the influence of the pretest level on the raw change score. The influence of 
comorbidity on the residual gain score was evaluated using linear regression 
analysis with the residual gain score on the STAI-State as the dependent variable 
and group as independent variable. These analyses were done comparing pretest 
with posttest, pretest with follow-up I and pretest with follow-up II. 
To analyse whether the course of remission across the three groups differed 
critically, Kaplan-Meier survival analyses were performed with patients with a 
score on the STAI-State of 34 and lower considered as remitted.  
Due to the relatively small sample size, only univariate analyses were run. All 
analyses were done on an intent-to-treat basis (n=139). For this analysis missing 
outcome values were substituted by the last value obtained. These analyses were 
repeated in the completer sample (n=109), but because the results of the intent to 
treat analyses corroborated the completer analyses, only the former are discussed. 
Results 
Characteristics at pretest 
Characteristics at pretest are presented in Table 1. The intent to treat sample 
(n=139) consisted of 52 males and 87 females with a mean age of 39 years (SD = 13 
years). The three groups differed significantly on the proportion of patients 







employed, the proportion of patients with comorbid GAD, the proportion of 
patients with comorbid obsessive compulsive disorder (OCD), and the mean 
number of SCID diagnoses. By definition, in the ‘no comorbidity’ group the 
number of SCID diagnoses was 1 and significantly smaller than the mean number 
of SCID diagnoses in the other two groups. In addition, the mean number of SCID 
diagnoses in the group ‘comorbidity among anxiety disorders’ was significantly 
smaller than the mean number of SCID diagnoses in the group ‘comorbidity with 
mood disorders’. 
 
Table 1: Pretest demographic characteristics of the comorbidity groups (intent-to-treat sample) 




anxiety disorders (ii) 
n=56 
Comorbidity with 
mood disorders (iii) 
n=18 
Sex, male (%) 29(45) 18(32) 5(28) 
Mean age (SD) 37.5(12.0) 38.6(13.5) 41.8(12.8) 
Married (%) 26(40) 25(45) 7(39) 
Employed (%) 42(65)a 27(48) 6(33)a 
Higher education (%) 24(37) 22(39) 5(28) 
Diagnosis (%) 
Panic Disorder with/without 
Agoraphobia 
Generalized Anxiety Disorder 
Agoraphobia 
Social Phobia 
Obsessive Compulsive Disorder 
Simple Phobia 




















































Mean number of diagnosis (SD) 1(0)ba 2.3(.7)ac 3.4(1.3)bc 
Mean duration in years of anxiety 
disorder (SD) 
7.5(10.3) 9.7(12.9) 9.4(13.7) 
Randomisation to secondary care (%) 33(51) 23(41) 5(28) 
SD=Standard Deviation. a = significant difference between no comorbidity group and comorbidity among anxiety group. b = 
significant difference between no comorbidity group and comorbidtiy with mood disorder group. c = significant difference 
between comorbidity among anxiety group and comorbidity with mood disorder group. 
 
In Table 2 mean scores on the STAI-State are shown for the three groups on the 
four measurements. The three groups improved significantly between pretest and 
posttest. Between posttest and the two follow-ups in none of the three groups 







significant improvements emerged. Of the three groups, the group ‘comorbidity 
with mood disorders’ had the most severe score on all measurements, while the 
‘no comorbidity’ group had the least severe scores. The group ‘comorbidity among 
the anxiety disorders’ occupied an intermediate position on the four 
measurements. 
 
Table 2: Pretest, posttest, follow-up 1 and follow-up 2 STAI-State of study group (intent to treat-sample) and 
One way ANOVA 




anxiety disorders (ii) 
n=56 
Comorbidity with 




Scale range Mean SD Mean SD Mean SD  
STAI State 20-80        
pretest  46.2 13.4 52.2 12.2 60.2 7.4 1<2;1<3 
posttest  40.9 13.1 43.6 11.2 52.3 12.3 1<3;2<3 
follow-up 1  39.0 12.2 43.8 11.6 51.5 10.4 1<3 
follow-up 2  38.0 12.4 42.6 12.6 50.7 12.7 1<3 
n=number of patients. ANOVA=Analysis Of VAriance SD=Standard Deviation. STAI=Spielberger State-Trait Anxiety Inventory. 
Significant time effect (pretest-posttest/pretest- follow-up 1/pretest- follow-up 2) in the no comorbidity group, the comorbidity 
among anxiety disorders group and the comorbidity with mood disorders group. The greatest time-effect is find between 
pretest and posttest and stayed in most of the groups stable during follow-up period. 
 
Attrition 
Participants were considered dropout when they did not fill out follow-up II. From 
pretest to follow-up II test 8 of 65 participants (12%) were considered dropouts in 
the ‘no comorbidity’ group versus 18 of 56 participants (32%) in the group 
‘comorbidity among the anxiety disorders’ and 4 of 18 participants (23%) in the 
group ‘comorbidity with mood disorders’ (Chi square (df = 2) = 7.0; p = .03). 
Dropouts (n=30) did not differ significantly from the completers (n=109) on any 
variable presented in the Tables 1 and 2. For an overview see Figure 1. 
Influence of comorbidity on change scores 
To analyse whether the improvement among the three groups differed, three 
regression analyses were done on the STAI-State with the residual gain scores 
between pretest and posttest, pretest and follow-up I and pretest and follow-up II 
as the dependent variable and group as independent variable. Relative 
improvement diverged critically across the three groups between pretest and 
follow-up I respectively pretest and follow up II (pretest vs. posttest: F (df = 2) = 
34.41; p = .35; pretest vs. follow-up I: F (df = 2) = 27.71; p = .03; pretest vs. follow-







up II: F (df = 2) = 21.58; p = .04). Pairwise comparisons indicated that the group 
‘comorbidity with mood disorders’ improved less between pretest and follow-up I 
respectively pretest and follow-up II compared with the improvement of the ‘no 
comorbidity’ group and the ‘comorbidity among anxiety disorders’ group (due to 
the small sample size of the ‘comorbidity with mood disorders’ group, these 
pairwise comparisons yielded trends only: 0.05 < p < 0.13).  
Influence of comorbidity on remission 
In figure 2 the percentages of remission across the three groups on the STAI state 
are shown. Kaplan-Meier survival analysis revealed significant differences across 
the three comorbidity groups (Log Rank: 10.16 (df=2); p=.006). Pairwise 
comparisons showed significant differences: ‘no comorbidity’ vs. ‘comorbidity 
with mood disorders’ (Log Rank: 9.53 (df=1); p=.002; Relative Risk (R.R.): 5.0; 95% 
Confidence Interval (95% C.I.): 2.11-46.74); ‘comorbidity among anxiety disorders’ 
vs ‘comorbidity with mood disorders’ (Log Rank: 5.38 (df=1); p=.020; R.R.: 3.91; 
95% C.I.: 1.25-28.5). No significant difference emerged between the ‘no 
comorbidity’ group and the ‘comorbidity among anxiety disorders’ group (Log 
Rank: 2.04 (df=1); p=.15; R.R.: 1.3; 95% C.I.: 0.80-3.40). To study whether correcting 
for pretest scores on the STAI-State influenced the results on the remission rates, 
Cox regression analyses were performed with the STAI-State pretest score entered 
into the regression analysis in the first step, followed by ‘group’. Now, the three 
groups did not differ significantly any more on remission rates.  
In addition, Kaplan-Meier survival analyses were run for each of the possible 
confounding variables (i.e. those variables with significantly different scores 
between ‘comorbidity among anxiety disorders’ and ‘comorbidity with mood 
disorders’; see Table 1). None of these variables yielded different remission rates 
among the three groups: employment (Log Rank 1.10 (df=1); p=.29), proportion of 
GAD (Log Rank 1.58 (df=1); p=.21), proportion of OCD (Log Rank 0.57(df=1); 
p=.45), and the number of SCID diagnoses divided into 6 groups did not appear to 




























No comorbidity n=65 Comorbidity among anxiety disorders n=56
Comorbidity with mood disorders n=18
 
Discussion 
It may be concluded that in a sample of primary care PA and GAD patients type of 
comorbidity critically influenced outcome of cognitive behavioural therapy: (i) 
Although all groups improved, the patients in the groups ‘no comorbidity’ or 
‘comorbidity among the anxiety disorders’ improved more than those with 
‘comorbidity with mood disorders’. (ii) Moreover, the groups ‘no comorbidity’ or 
‘comorbidity among the anxiety disorders’ had at least a four times higher chance 
to remit than those with ‘comorbidity with mood disorders’ (apart from the index 
anxiety disorder). In contrast, the residual gain scores and the remission scores of 
the groups ‘no comorbidity’ and ‘comorbidity among the anxiety disorders’ did 
not differ critically. In addition, in the present study it was found that patients with 
anxiety disorders with comorbid mood disorders suffer from more severe anxiety 
symptoms. During the whole follow-up period, this group remained the most 
severe. 
Our results fit well in the existing literature on the influence of comorbidity 
between anxiety and mood disorders: it has been found repeatedly that patients 







with comorbid anxiety and mood disorders have more severe complaints 
(Andrade et al, 1994; Grunhaus et al, 1994; Kessler et al, 1994; Brown et al, 1995; 
van Balkom et al, 2000) and poorer outcome of treatment focussed on the anxiety 
disorder (Keijsers et al, 1994; Pollack et al, 1994; Corominas et al, 2002; Shankman, 
2002). Our results expand on the literature by the finding that not comorbidity in 
itself necessarily affects severity and outcome negatively, but rather type of 
comorbidity. The results of the present study suggest that comorbidity of anxiety 
and mood disorders has a more negative influence than comorbidity among the 
anxiety disorders. 
The influence of type of comorbidity on outcome could be studied in this RCT and 
its 52-week follow-up, because pure and comorbid patients with panic disorder 
with or without agoraphobia or generalised anxiety disorder were included. We 
chose to increase the external validity of our results by including comorbid patients 
because clinicians often point at the problem of translating the results of RCT’s to 
their daily practice. They justly point out that they are confronted only rarely with 
the kind of ‘pure’ patients usually selected for standard RCT’s. Recently, this 
criticism has been confirmed by a study which found that only 14% of patients 
with a depressive disorder with a strict clinical profile qualified for a RCT with 
antidepressants (Zimmerman et al, 2002). Due to the broad inclusion criteria of the 
present study we could include patients comparable with those of every day 
practice. 
A limitation of this study is the relative small sample size (especially in the group 
‘comorbidity with mood disorders’) resulting in reduced statistical power. Thus, 
we could not control in statistical analyses for confounding variables, such as the 
rate of employment, the proportion of patients with comorbid GAD, the 
proportion of patients with comorbid OCD and the mean number of diagnoses 
which differed significantly across the three groups. However, in univariate 
Kaplan-Meier analyses we could not find significant relations between these 
variables and remission rates. Another limitation holds the type of treatment 
studied here: all patients received a form of cognitive behavioural therapy. It may 
be that in case the patients comorbid with mood disorders would have been 
treated with antidepressants, outcome would have been better. Given these 
limitations, the present results await corroboration from future research. 
Despite the small sample size, the results suggest indicate a differential effect of 
type of comorbidity. The presence of mood disorders with anxiety disorders 
predicts poorer treatment outcome compared with the presence of one or more 
anxiety disorders. The data suggest that rather than the number of comorbid 







disorders, type of comorbidity critically predicts outcome. These findings have 
major implications for clinical practice: First, it appears to be important to reliably 
diagnose comorbid mood disorders when anxiety disorders are present because 
this critically influences prognosis. Second, in anxiety disorder patients with 
comorbid mood disorders cognitive behavioural therapy alone may not be the 




























Figure 1: Recruitment to analysis 
 
CBT = cognitive behaviour therapy. ITT = Intention-to-treat 
Intake session SCID DSM IV
Assessed for eligibility n=229 
Manual (n=157) Guidelines (n=72) 
Included n=141











not meeting inclusion criteria 
(n=25) 
refused to participate (n=2) 
Informed consent n=154
Excluded n=48 
not meeting inclusion criteria 
(n=45) 
refused to participate (n=3) 
Dropout 
lost to follow up 2 
n=8 
Excluded (n=13) 
Did not fill out the pretest n=8 
Did not receive treatment n=5 
Comorbidity







lost to follow up 2 
n=18 
Dropout
lost to follow up 2 
n=4 
Analysed completers n=57
Analysed ITT n=65 
Analysed completers n=38
Analysed ITT n=56 
Analysed completers n=14 
Analysed ITT n=18 
Reasons for dropout:
Not reached in time for posttest 
and follow up 2 (n=1) 
Not reached in time for follow 





Refused to fill out posttest, fu1 




Refused to receive treatment 
(n=1) 
Comorbidity
among anxiety disorders 
n=56 
Reasons for dropout:
Not reached in time fu2 (n=8) 
Not reached in time fu1 and fu2 
(n=1) 
Not reached in time posttest, 
fu1 and fu2 (n=1) 
Refused to fill out fu1 and fu2 
questionnaires (n=4) 
 
Refused to fill out posttest, fu1 




Refused to receive treatment 
(n=2) 
Reasons for dropout: 
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In this final chapter the main findings and conclusions of this study are critically 
discussed. The main purpose of this study was to investigate the potential of self-
help treatment for anxiety disorders in primary care. Anxiety disorders are 
prevalent in primary care and the number of studies targeted at this population is 
limited, while it is evident that treatments designed for secondary care are usually 
not feasible for primary care because they require too much time investment. In the 
Guidelines for treatment of anxiety disorders developed by the Dutch College of 
General Practitioners (referred to henceforth as Guidelines), self-help is not 
mentioned as an option, which motivated us to this study. From a literature review 
it followed that self-help shows sufficient effectiveness, but that results improve 
when some additional time is available from a supporting figure such as a general 
practitioner (GP) to keep the patients on the self-help program. Subsequently, we 
developed a self-help manual for two prevalent anxiety disorders in primary care, 
panic disorder with of without agoraphobia and generalized anxiety disorder, 
which included guidance from the GP, resulting in guided self-help treatment 
(referred to from now on as Manual). In a number of n=1 studies we found that 
Manual was feasible and led to improvement in the primary care patients treated. 
The main goal of the study was to compare the effectiveness of a guided self-help 
treatment for panic disorder and generalized anxiety disorder with the Guidelines 
of the Dutch College of General Practitioners. As these Guidelines have not yet 
been studied for their effectiveness, Cognitive Behaviour Therapy as practiced in 
secondary care was used a third condition and as “gold standard”. A special 
feature of this study was that primary care treatments for primary care patients 
were compared to a secondary care treatment for the same population. It was 
expected that Cognitive Behaviour Therapy delivered by experienced therapists, as 
evidence based secondary care therapy, would be more effective than Manual or 
Guidelines as delivered by the GP’s. The main finding of the RCT comparing CBT, 







Manual and Guidelines was that no difference in outcome was observed between 
the three treatment types.  
We also investigated the effect of comorbidity on long term outcome and found 
that comorbidity with depression led to a lower rate of remission, while 
comorbidity with other anxiety disorders did not.  
In this chapter, we will discuss the strengths and weaknesses of several aspects of 
the study. First the recruitment procedure of general practitioners and patients will 
be reviewed. The next topics will be the specific disorders chosen in the study and 
the differences in diagnostic procedures in primary and secondary care. The 
outcomes for the different treatment types will be discussed. In conclusions, we 
will consider the relevance of this study for clinical practice and make some 
suggestion for further research. 
Recruitment of general practitioners 
and patients 
GP’s have had a central role in this study. They were asked to participate actively 
in the recruitment of patients, to follow training instructions and to conduct the 
treatment of their patients according to either the Manual or the Guidelines.  
It proved to be rather difficult to find enough GP’s who were willing to collaborate 
in this project. GP’s were approached by written invitation and through personal 
contact. Participation of one member of a group practice often led to participation 
of other members of that group. Practitioners with little affinity for mental health 
problems tended not to enrol in the study. Randomisation at the practice level was 
chosen in order to avoid contamination between the treatment conditions (Hox, 
1995). Although recruitment was limited to the Amsterdam region, some GP’s 
refused participation because of the distance of their practice to the clinic where 
the training was given. For the above reasons, we cannot claim that the GP’s 
participating in the study are entirely representative for GP’s in general, which 
limits the generalisability of our study.  
Another factor that limits generalisability is that GP’s who were randomised to the 
Guidelines tended to lose interest in the study and enrolled fewer patients than 
their colleagues randomised to the Manual. Some GP’s expressed their 
disappointment at not being allotted to the Manual, which clearly had more appeal 
because it was new. Other reasons given for not including more patients were that 
the right type of patients were not seen in the practice, patient refusal or the need 







to start treatment without any delay. Since these reasons were invoked more often 
in the Guidelines than in the Manual, a difference in motivation suggests itself. 
Despite efforts as suggested in the literature (Murphy et al, 1992) to keep up the 
involvement of all GP’s by newsletters, meetings and personal contact, the 
recruitment of patients remained unbalanced with a lower influx in the Guidelines 
group. This problem is not unusual when one wishes to compare a new treatment 
with care as usual, but a marked difference in referral patterns weakens the 
internal validity of a study. A partial solution to this imbalance would be to 
include more GP’s in the condition that is expected to deliver less referrals. 
Although we did try to correct the imbalance by recruiting extra GP’s, with an 
uneven ratio of randomisation over Manual and Guidelines, an equal distribution 
of patients over the three cells was not achieved. If one chooses to completely 
eliminate the influence of the person of the GP and his preferences, a recruitment 
procedure must be organised in which the GP plays no selecting role and 
treatment must be delivered by other therapists. This, of course, seriously 
endangers the external validity of any primary care treatment study. However, as 
no differences in outcome were found between the treatments, the consequences of 
this unbalance seem to be limited. A more serious problem of interpretation would 
have arisen if Manual would have had a better outcome than the Guidelines.  
Screening and diagnosis 
Selection of patients was initiated by the GP when there was a suspicion of an 
anxiety disorder. The GP then screened the patient with the Short and Simple 
Screening Interview (SSI) by Goldberg et al (1988). GPs were previously trained in 
the use of this instrument. Patients with a score of 5 or more were referred to the 
study for further diagnosis. This consisted of a two- hour interview including a 
SCID-IV diagnostic interview (First et al, 1997) to establish a DSM-IV diagnosis. 
The interview was conducted by diagnosticians in the out patient department of 
psychiatry. A number patients were lost to the study through this procedure. For 
some, the time involved was more than they wished to make available and for 
others it was too threatening to visit a psychiatric department. In retrospect, this 
could have been avoided by organising the diagnostic session in the GP’s practice. 
This would, of course, have involved more travelling time for the diagnosticians. 
On the other hand, interview time might have been shortened by using a less time 
consuming instrument than the SCID-IV, such as the PRIME-MD (Spitzer et al, 
1994) or the Anxiety Disorder Interview Schedule (ADIS; Brown et al, 2001). 
Organizing the diagnostic procedure within the primary care practice probably 
would have benefited the recruitment rate of this project.  







Panic disorder and 
generalised anxiety disorder 
In this study treatment was offered for two anxiety disorders rather than one. 
Arguments in favour of this decision were that they are the most prevalent anxiety 
disorders in primary care (Regier et al, 1988; Bijl et al, 1997), that they frequently 
occur as co morbid disorders, and that is feasible to make an effective treatment 
manual for the combination of the two disorders. It can be argued that with 
specific manuals for each disorder higher effect sizes could be expected. However, 
in primary care specific diagnostic groups are usually not as clearly separated as 
they are in secondary care (Terluin et al, 2004). Furthermore, panic disorder (PD) 
and generalised anxiety disorder (GAD) are rather comparable in nature and 
intensity of various symptom domains, social and work related disabilities 
(Mavissakalian & Zamar, 2000). In this study 75 patients were included with PD 
without GAD, 26 with GAD without co morbid PD and 40 with both GAD and PD. 
No differences between these subgroups emerged on pre-treatment characteristics, 
on symptom severity or dropout rate and no differences were found in treatment 
effect. Consequently, the lumping together of these disorder in future studies 
seems justifiable.  
Comorbidity 
As the aim of the project was to study effectiveness rather than efficacy, inclusion 
was not limited to pure PD or GAD, but comorbidity was allowed as long as these 
anxiety disorders could be considered as the primary diagnosis. Clinical relevance 
of efficacy studies is as a rule limited because only a small segment of the patients 
seen in clinical practice is enrolled. Patient selection in this study is a better 
reflection of anxiety disorder patients seen in primary care and selected by their 
GP, while at the same time strict diagnostic criteria with SCID-IV are available. 
Clinicians often point at the problem of translating the results of an RCT to their 
daily practice. They state that they are confronted only rarely with the kind of 
“pure” patients usually selected for these RCT’s. Recently, this criticism has been 
confirmed by a study which sought to determine whether patients with a current 
major depression participating in antidepressants efficacy trials are representative 
of depressive patients in the real world. This seemed not to be the case: only a 
small subset of patients (about 14%) with a strict clinical profile qualified for 
efficacy trials, which severely restricts the external validity of the results. Although 
this study dealt with efficacy trials of treatment of depression, its results can well 
be extended to the same kind of trials in other areas of psychiatry (Zimmerman et 







al, 2002). We chose to increase the generalisability of our results by including 
patients with a comorbid diagnosis of a mood, anxiety, somatoform disorder or 
substance dependence. 
Treatment effects 
For the researchers it was a surprising finding that the three treatment conditions, 
Manual, Guidelines and CBT had an equal outcome. Lack of power is one possible 
explanation of negative findings in comparative outcome studies. Although the 
total inclusion was lower than planned, lack of power is not the best explanation 
for our findings. A considerably larger inclusion of patients might have shown 
statistically significant differences in outcome, but then clinical significance would 
have been very dubious.  
Most unexpected was that CBT delivered by experienced therapists in a specialized 
outpatients clinic failed to show better results than the two primary care 
interventions which are considerably less time intensive and need less expertise. In 
terms of effect size, results obtained by CBT were at the lower end of the range of 
effect sizes found in other studies with CBT, but not outside that range. There are 
no reasons to assume that the therapists put in less of an effort for this study, so 
other explanations must be considered. One possible explanation could be that 
there was “less room for improvement” due to the assumption that the primary 
care patients had a lower level of symptoms compared to the patients usually 
treated in secondary care, symptom improvement must necessarily be more 
modest. Another explanation was the observation that a rather high number of 
patients declined to participate in treatment at the Psychiatric Outpatient Clinic, 
dropped out of CBT or failed to complete the twelve sessions of CBT that were 
planned. Several patients mentioned that the therapy they were offered was rather 
more intensive than they had wished for and involved more time than they were 
willing to devote. Apparently, their anxiety disorder was less of a burden than for 
most patients usually seen in specialized care for whom CBT is designed.  
Of course, these findings fit very well with the Goldberg and Huxley (1992) model 
of filters operating in mental health: only patients with higher levels of 
psychopathology tend to be referred from primary to secondary care.  
No data were available on the effectiveness of the Guidelines, therefore it was not 
possible to make a prediction about it’s effectiveness compared to the other 
treatment modalities. Nonetheless, it was a surprise that the Guidelines did as well 
as it did. The fact that fewer patients were referred to the Guidelines, and fewer 







GP’s made referrals to the study deserves some comment. It was mentioned 
already that some GP’s expressed disappointment al being randomised to the 
Guideline condition rather than the Manual and some appear to have lost interest 
in the study altogether. It may be that those GP’s remaining in the study in the 
Guidelines group had a more than average interest or proclivity in applying the 
Guidelines, and being a positive selection, they might have obtained better results. 
As the Guidelines is a “package” rather than a single intervention, it is not possible 
to decide what made the Guidelines effective. Almost half of the patients treated in 
the Guidelines group received either medication or referral, so one can speculate 
that these are important elements for it’s effectiveness. This study demonstrates 
that several GP’s seem to have little enthusiasm for the Guidelines, but others 
appear to be able to manage anxious patients very well by applying the Guidelines.  
The guided self-help treatment also proved to be an effective intervention. It was 
found to be feasible for GP’s, apparently generating more interest and enthusiasm 
than the Guidelines. This of course may be a temporary phenomenon, due it’s 
novelty. However, as the Manual contained practically useful elements such as the 
psycho-education, the relaxation tape, the explanation of cognitive principles and 
exposure, it is not surprising that GP’s appreciated the Manual as a useful aid in 
the management of anxious patients.  
The improvement in all conditions was maintained on the longer term. For CBT 
this was no surprise, since it has been demonstrated repeatedly that the results of 
CBT are usually lasting and even further improvement after treatment may occur. 
Apparently, both the Manual and the Guidelines also contained the elements that 
contribute to this stabilising effect. 
Strictly speaking, we have no certainty that the improvement noted was really due 
to the interventions. For this we should have needed a no-treatment group that 
would reveal the natural course of the disorders. Not only is this hard to achieve in 
a primary care study, it would also have burdened the design. In secondary care it 
is well documented that anxiety disorders tend to remain chronic, with little 
spontaneous improvement. This may be less true of anxiety disorders in the 
general population and in primary care, although clear data are lacking (Wittchen, 
1988; Yonkers et al, 1996). A certain amount of spontaneous recovery, especially on 
the long term is to be expected. However, this would not have reached the level of 
improvement seen in this study.  
Rather than a no-treatment condition, we chose for a Treatment as Usual in the 
form of the Guidelines. We do not know to what extent this is really the treatment 
that is usually applied, since the systematic implementation of the Guideline has 







yet to be started. But as the Guideline contains a wide scope of possible 
interventions, it is reasonable to assume that Usual Practice will most often be 
within the limits of the Guidelines.  
Implications for Patient Care 
The results of the present study strongly support the existing practice of referring 
only a selection of anxiety disorder patients to specialised secondary care. No 
superior results would be achieved if all anxiety disorder patients would receive 
CBT as offered in specialised institutions. For anxiety disorders, this study 
supports the rationality of the Goldberg and Huxley Filter model for delivery of 
care.  
This study also supports the position that evidence based treatments that have 
been developed and tested in secondary care should not be exported without 
modifications to primary care. Rather, less time intensive and more easy to deliver 
formats should be developed, a process that is already under way in for example 
Problem Solving Therapy (Wilkinson & Mynors-Wallis, 1994). This means that 
interdisciplinary Guidelines as recently developed in the Netherlands should have 
the option of separate recommendations for primary and secondary care.  
On the basis of this study, it can also be recommended to include guided self-help 
treatment in future Guidelines for General Practice. The guided self-help treatment 
may be a concrete way to support the GP in delivering elements that are part of the 
Guidelines that are otherwise time consuming, such as the explanation of cognitive 
principles. This would not entail a superior effect, but would rather contribute to 
feasibility. The present study suggests that the reception of this addition among 
GP’s would not be negative. The guidance that is part of the treatment could also 
be delivered by other primary care workers than the GP, such as nurses or social 
workers.  
Suggestions for future research 
In future studies on course and treatment outcome of anxiety disorders it would be 
wise to treat primary care and secondary care patients as separate populations. 
Results from an unspecified mix of patients might rather add to confusion than to 
clarification. However, this recommendation will be harder to follow in countries 
where the Health Care System lacks clear boundaries between primary and 
secondary care. 







At this point it is not clear whether comorbidity with depression would suggest 
another course. This should be a point further studies  
The model of guided self-help treatment could be studied for other disorders such 
as depression or somatoform disorder.  
Another modality of interest is that of the computer assisted programs. Several 
initiatives have been deployed and show interesting effects (Schneider et al, 2005). 
Both guided self-help treatment and computer assisted treatment could become 
part of an evidence based stepped care program in primary care. However, this 
implies that the current trend of supporting the GP with other disciplines is 
continued. 
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Toepasbaarheid en effectiviteit van behandeling voor 
angststoornissen in de eerste lijn 
 
 
Dit proefschrift heeft als onderwerp de toepasbaarheid en effectiviteit van een 
zelfhulpbehandeling met begeleiding door de huisarts (begeleide zelfhulp) bij 
patiënten met paniekstoornis met of zonder agorafobie (PA) en/of 
gegeneraliseerde angststoornis (GAS) in de eerste lijn. Een vergelijking werd 
gemaakt met de standaardbehandeling in de eerste lijn (NHG - standaard 
angststoornissen: NHG) en de ‘gouden standaard’ in de tweede lijn (cognitieve 
gedragstherapie: CGT). 
Hoofdstuk 1 gaat in op het klinische beeld, diagnostiek, voorkomen 
(epidemiologie), herkenning in de eerste lijn en gelijktijdig voorkomen met andere 
aandoeningen die patiënten met PA en GAS vaak hebben (co-morbiditeit). 
Vervolgens worden de NHG, CGT en de begeleide zelfhulp besproken. Tot slot 
van dit hoofdstuk worden de onderzoeksvragen van het proefschrift uiteengezet. 
Uit onderzoek blijkt dat er veel patiënten voorkomen met angststoornissen. PA en 
GAS komen het meest frequent voor. Aangezien deze aandoeningen gepaard gaan 
met veel lichamelijke klachten, maken patiënten met PA en GAS zich vaak zorgen 
om hun lichamelijke gezondheid. Daardoor gaan zij vaak naar hun huisarts om 
geruststelling te krijgen. De huisarts probeert de patiënten gerust te stellen door 
laboratoriumonderzoek of lichamelijk onderzoek te laten uitvoeren of door te 
verwijzen naar een medisch specialist.  
Wanneer de lichamelijke klachten niet herkend worden als behorend bij PA of GAS 
blijven deze klachten bestaan en krijgen patiënten geen behandeling voor hun 
angstklachten. Dat is jammer, omdat uit onderzoek is gebleken dat PA en GAS 
kunnen verbeteren met een psychologische behandeling, cognitieve 







gedragstherapie genaamd. Deze behandeling is meestal niet toe te passen door de 
huisarts vanwege de intensiteit. 
De NHG -standaard angststoornissen is tot op heden niet onderzocht op 
effectiviteit. Ook lijkt de toepasbaarheid ervan moeilijk, omdat de huisarts volgens 
de Standaard simpele cognitieve gedragstherapie moet uitvoeren. In dit onderzoek 
willen we aandacht vestigen op dit probleem en uitzoeken of een door ons 
ontwikkelde zelfhulpbehandeling effectief voor PA en GAS toepasbaar is bij de 
behandeling van deze aandoeningen in de eerste lijn. Uit de literatuur blijkt dat 
zelfhulpbehandelingen effectief kunnen zijn in de eerste lijn. Tevens blijkt dat 
begeleiding van zo’n zelfhulpbehandeling door een behandelaar (de huisarts 
bijvoorbeeld) deelname aan de behandeling verhoogt en het effect mogelijk groter 
wordt. Daarom kozen we ervoor om begeleiding door de huisarts toe te voegen 
aan de zelfhulpbehandeling. 
Het proefschrift bestaat uit (i) een literatuuronderzoek naar het effect van in ander 
onderzoek geëvalueerde zelfhulpbehandelingen, (ii) een pilot studie naar de 
effectiviteit en toepasbaarheid van de begeleide zelfhulp, (iii) een randomised 
controlled trial (RCT) waarin de effectiviteit van deze begeleide zelfhulp 
vergeleken wordt met de effectiviteit van de NHG Standaard angststoornissen en 
cognitieve gedragstherapie uitgevoerd in de tweede lijn en (iv) de invloed van 
bijkomende stoornissen op de uitkomst van de behandelingen die werden 
onderzocht in de RCT. 
Hoofdstuk 2 is een literatuuroverzicht van studies naar de effectiviteit van 
zelfhulpbehandeling bij patiënten met angststoornissen in de eerste lijn tussen 1963 
en 2003. Zes geïdentificeerde gerandomiseerde studies werden vergeleken op 
uitkomst en gecodeerd op kwaliteit. Er was een verschil in methodologische 
kwaliteit, gebruikte meetinstrumenten en het aantal patiënten dat meedeed in de 
studie. Ondanks deze verschillen waren globale bevindingen dat zelfhulp een 
effectieve behandelingsmogelijkheid is bij patiënten met angststoornissen in de 
eerste lijn. Tevens vonden we dat hoe meer tijd er besteed werd aan begeleiding 
van het gebruik van de zelfhulphandleiding, hoe groter het effect van de 
behandeling was. Er bleken geen gegevens te zijn gepubliceerd over de 
toepasbaarheid en kosteneffectiviteit van zelfhulpbehandelingen. 
In hoofdstuk 3 wordt het effect en de toepasbaarheid van de nieuw ontwikkelde 
zelfhulpbehandeling met begeleiding in een pilot studie met 5 geselecteerde 
eerstelijns patiënten met PA en/of GAS onderzocht. De begeleide 
zelfhulpbehandeling wordt gedetailleerd beschreven. Kort samengevat gaat het 








gedragstherapeuten. Eerder verschenen Engelstalige zelfhulpboeken voor 
patiënten met paniekstoornis, vermijding en gegeneraliseerde angststoornis. Ook 
werd eerder een zelfhulphandleiding ontwikkeld voor sociale fobie. 
De zelfhulphandleiding bestaat uit een introductie, uitleg over angst, cognitieve 
technieken, ontspanningsoefeningen en oefenen in het echte leven. De patiënt 
wordt geadviseerd de behandeling over 12 weken te spreiden. Aan het eind van 
ieder hoofdstuk staan een aantal vragen over het voorgaande zodat de patiënt zelf 
kan controleren of hij de stof begrepen heeft. Tevens werd de patiënt geadviseerd 
de behandeling niet alleen te doen, maar een helper te zoeken. Met een folder over 
wat er van diegene verwacht wordt kon de patiënt een vriend of familielid vragen. 
Bij de handleiding hoort een geluidsopname van ontspanningsoefeningen, een 
registratieboek, een oefenboek en een boek met antwoorden op de vragen die na 
ieder hoofdstuk gesteld werden.  
De zelfhulphandleiding werd begeleid door de huisarts in 5 consulten die over 12 
weken verspreid werden. De begeleiding bestond uit het beantwoorden van 
vragen, het bespreken van de voortgang en het motiveren om door te gaan. In de 
pilot studie werd het effect geëvalueerd door middel van zelfrapportage 
vragenlijsten die voorafgaande en na afloop van de behandeling werden ingevuld 
door de patiënten. De meeste patiënten verbeterden gedurende de 
behandelperiode van 12 weken. Twee patiënten ‘genazen’ volgens de criteria van 
Jacobson en Truax. Geconcludeerd werd dat begeleide zelfhulp een effectieve 
behandelmogelijkheid kan zijn in de behandeling van PA en GAS in de eerste lijn. 
Deze conclusie kan echter pas getrokken worden nadat het effect van deze 
zelfhulpbehandeling in een gecontroleerde studie onderzocht is.  
In hoofdstuk 4 wordt de hoofdstudie van dit proefschrift besproken. Doel van deze 
gerandomiseerde gecontroleerde studie is de effecten van begeleide zelfhulp, de 
standaard angststoornissen van het Nederlands Huisarts Genootschap en 
cognitieve gedragstherapie met elkaar te vergelijken. De behandelingen duurden 
12 weken, waarna de patiënten bij 3 en 9 maanden vervolgd werden. De eerste 
twee behandelingen werden door 46 huisartsen uitgevoerd, die gerandomiseerd 
toegewezen werden voor een van deze behandelingen. CGT werd uitgevoerd door 
ervaren cognitieve gedragstherapeuten op de angstpolikliniek van GGZ-
Buitenamstel. Honderdvier en vijftig patiënten werden gerandomiseerd 
toegewezen aan een van de drie behandelingen. De uitkomst werd gemeten op de 
STAI-state, een meetinstrument waar mate van angst mee gemeten wordt. Alle 
drie de behandelingen gaven verbetering van de angstklachten. Uit de 
vervolgmomenten bleek dat dit effect behouden bleef. De gemeten verbetering 







verschilde niet tussen de behandelingen. De toepasbaarheid van de NHG-
standaard voor de eerste lijn bleek echter minder groot dan die van de begeleide 
zelfhulp. Geconcludeerd werd dat huisartsen de behandeling van PA en GAS zelf 
kan doen. Behandeling op een psychiatrische polikliniek middels CGT geeft geen 
beter resultaat voor deze eerste lijnspatiënten dan de beschreven eerstelijns 
behandelingen (zelfhulp en de NHG-standaard). Begeleide zelfhulp lijkt 
gemakkelijker toepasbaar voor de huisarts dan de NHG-standaard. 
In hoofdstuk 5 wordt bij 139 van de patiënten uit hoofdstuk 4 bekeken of het 
hebben van een andere psychische stoornis naast PA of GAS en in het bijzonder of 
een comorbide depressieve stoornis de verbetering van angstklachten door de 
behandeling beïnvloedt. Dit werd bekeken door middel van een zogeheten 
‘overlevingsanalyse’ van Kaplan-Meier. De 139 patiënten werden ingedeeld in de 
groepen (i) een angststoornis (PA of GAS); (ii) een angststoornis in combinatie met 
andere angststoornissen en (iii) een angststoornis en een depressieve stoornis. Een 
patiënt wordt bij nameting of vervolgmetingen als ‘genezen’ beschouwd als de 
score op de STAI-state 34 of lager was. Deze waarde is afgeleid uit gemiddelde 
scores op de STAI in een groep niet-angstige proefpersonen. In de groep met 
depressieve klachten genazen significant minder patiënten dan in de groep met 
meerdere angststoornissen en de groep met één diagnose. Er was geen verschil in 
genezing tussen de groep met één diagnose en de groep met naast deze diagnose 
tevens een comorbide andere angststoornis. Geconcludeerd wordt dat het hebben 
van een comorbide depressieve stoornis het effect van de behandeling van de 
angststoornis negatief beïnvloedt. Op grond van deze resultaten zou 
geconcludeerd kunnen worden dat voor eerste lijnspatiënten met een PA of een 
GAS in combinatie met een depressieve stoornis cognitieve gedragstherapie 
mogelijk niet de meest aangewezen behandeling is.  
In hoofdstuk 6 wordt nader ingegaan op belangrijke onderwerpen en bevindingen 
van voorgaande hoofdstukken. In dit hoofdstuk ligt de nadruk op algemene 
discussiepunten betreffende de wijze van werving, screening, keuze van 
angststoornis, comorbiditeit en behandeling van patiënten met angststoornissen 
binnen de eerste lijnsgezondheidszorg.  
In deze studie is gekozen de huisartsen een centrale rol te geven. Hen werd 
gevraagd om patiënten te screenen en een cursus te volgen om bij 2/3 van de 
ingesloten patiënten de eerste lijnsbehandeling uit te voeren. Het bleek moeilijk 
voldoende gemotiveerde huisartsen te vinden voor deze rol. De toewijzing aan de 
NHG-standaard behandeling had tot gevolg dat de huisarts interesse in het 








van de uitkomsten verminderd zijn. In een nieuwe studie zou dit voorkomen 
kunnen worden door huisartsen niet de selectie te laten doen en de behandelingen 
te laten uitvoeren door andere eerstelijns medewerkers.  
Wat betreft de screening was het opvallend dat patiënten moeite hadden met de 
duur van het interview. Daarnaast vond men moeilijk dat dit interview plaats 
vond in onze psychiatrische instelling. Het zou beter zijn geweest om een minder 
intensieve screening te gebruiken en deze in de eerste lijn te hebben laten 
plaatsvinden.  
De keuze van de combinatie van paniekstoornis en gegeneraliseerde angststoornis 
in deze studie kon onderbouwd worden vanuit andere studies. In onze studie 
bleek geen verschil in resultaat te bestaan tussen de twee angststoornissen. Het 
includeren van patiënten met comorbide stoornissen maakt de uitkomst van deze 
studie generaliseerbaar naar de algemene praktijk. Tevens kon de invloed van 
comorbiditeit worden bestudeerd op de uitkomst van de behandeling. 
Een voor ons onverwachte uitkomst was dat het effect in de RCT voor de 
verschillende behandelingen gelijk was. Dit suggereert dat verwijzing naar de 
tweede lijn alleen voor een geselecteerde groep patiënten zinvol is. Er lijkt geen 
extra effect te verwachten als alle patiënten met angststoornissen CGT zouden 
krijgen. Tevens blijkt dat CGT niet naar de eerste lijn verplaatst moet worden, maar 
een minder intensieve behandeling een even goed resultaat biedt. 
Geconcludeerd kan worden dat laagdrempelige selectie en zorg relevant zijn voor 
de praktijk. Hierdoor zullen patiënten eerder herkend worden en eerder 
behandeling krijgen. Daardoor zal mogelijk de kans op chronische klachten of 
oneigenlijk gebruik van de somatische gezondheidszorg voorkomen kunnen 
worden. Tevens zal het door deze effectieve behandeling het ziekteverzuim en 
functioneren in de gezins- en sociale bezigheden verbeteren. De begeleide zelfhulp 
kan naast in de 1ste lijn (mogelijk als onderdeel van de NHG-standaard 
behandeling) ingezet te worden mogelijk ook geïntroduceerd worden in de 0de 
lijn. De begeleiding kan ook door een andere eerstelijnsmedewerker, als een eerste 
lijnspsycholoog, een sociaal-psychiatrisch verpleegkundige of maatschappelijk 
werker worden uitgevoerd. De toegankelijkheid is groter in de 0de en 1ste lijn 
doordat minder stigmatisatie van de patiënten en er zullen dus meer patiënten 
bereikt worden. De kosten zullen voor deze behandeling zeker lager liggen dan die 
in de 2de lijn. Mocht er sprake zijn van ernstigere angstklachten, dan moet gekeken 
worden of er sprake is van bijkomende angststoornissen of depressie en kan een 
intensievere behandeling meer aangewezen zijn. 







De effectiviteit van een gemakkelijk uit te voeren en goedkope behandeling als de 
hier onderzochte zelfhulp handleiding kan een oplossing vormen voor de relatief 
schaarse mogelijkheid tot hulpverlening binnen de Geestelijke gezondheidszorg 
(GGZ). Vervolgonderzoek met deze vorm van behandelen in de eerste lijn lijkt dan 
ook zinvol te zijn. Er kan in dit onderzoek bijvoorbeeld ingegaan worden op de 
toepasbaarheid en effectiviteit van een begeleide zelfhulp voor een bredere groep 
patiënten, waarbij zowel angststoornissen als depressie meegenomen worden in de 
behandeling. Dit idee komt voort uit de bevinding dat een comorbide depressie 
een negatieve invloed heeft op de uitkomst van een behandeling voor PA en GAD 
alleen. Tevens kan onderzocht worden of discipline van de begeleider in de 
begeleide zelfhulp uitmaakt. 
Gedacht kan worden aan het vergelijken van het effect van verpleegkundige of 
maatschappelijk werkende met de huisarts. Een vergelijkende studie tussen 
zelfhulp en medicatie lijkt daarentegen niet zinvol te zijn. Er is recent gevonden 
dat er geen verschil in effectiviteit bestaat tussen medicatie en psychotherapie bij 
milde tot matig ernstige klachten. In toekomstige studies kan ook het 
kosteneffectiviteits aspect van begeleide zelfhulp ten opzichte van andere 
behandelingen worden onderzocht. Voor zover nu onderzocht lijkt de in deze 
studie gevonden toepasbaarheid en effectiviteit van een begeleide 
zelfhulphandleiding een uitstekende oplossing te vormen voor zowel vele eerste 

















Het is zover. Mijn proefschrift is af. Er zijn velen die ik graag wil bedanken. Zij 
hebben in de afgelopen 11 jaar meegewerkt aan dit resultaat. 
Het begon voor mij in het Johan Weijer Instituut van de Valeriuskliniek. Désirée 
Oosterbaan attendeerde me op een AGNIO-plek op de angstpolikliniek. Daar is 
mijn loopbaan in de onderzoekswereld begonnen. Jij bent al jaren mijn vriendin. Jij 
wekte mijn belangstelling in het doen van onderzoek, doordat ik meewerkte aan 
jouw promotieonderzoek. In die tijd was er een vacature voor een AGIKO-plek 
binnen de Valeriuskliniek. Dit maakte het voor mij mogelijk om de opleiding tot 
psychiater te combineren met het doen van onderzoek en het werken in de eerste 
lijn. Désirée, het was fijn samen met jou AGIKO te zijn. Nog vaak denk ik terug 
aan de gezellige ‘AIO-controles’, lunches en concertgebouwbezoekjes, om onze 
hersencellen te verfrissen, te spuien en constructief na te denken over hoe de 
AGIKO-periode door te komen. Ik hoop en wens dat onze vriendschap en het 
delen van onze ervaringen over ons werk voor altijd mogen blijven bestaan! 
Mijn onderzoeksgroep wil ik bedanken voor het geduld en de samenwerking in 
deze lange periode. Ton van Balkom, mijn eerste promotor, in deze hele periode 
was jouw doorzettingsvermogen voor mij een ‘motor’. Richard van Dyck, mijn 
tweede promotor, jij hebt me niet laten zitten, jouw steun heb ik gewaardeerd. Jij 
maakte het mogelijk dat het onderzoek bijna ongestoord vervolgd kon worden 
tijdens de periodes dat ik met een opleidingsstage bezig was. Patricia van Oppen, 
mijn copromotor, jij gaf vorm aan de cognitieve gedragstherapie. Onmisbaar vond 
ik jouw begeleiding in meedenken, meeschrijven en meewerken in meerdere 
aspecten van het onderzoek. Nettie Blankenstein, jij dacht mee over samenwerken 
met huisartsen in onderzoeksverband. Sako Visser, jij was vast aanspreekpunt over 







de cognitieve gedragstherapie en deed zelf ook enthousiast een paar 
behandelingen. 
De huisartsen die meewerkten aan het onderzoek, dank jullie wel voor de prettige 
samenwerking. Zonder jullie was er geen onderzoek en geen uitkomst geweest. 
Willem Feijen uit Delft, bij jou kon ik een pilot doen, zodat we wisten waar we 
tegen aan zouden lopen tijdens de zelfhulpbehandeling. Dank ook aan de 
patiënten uit jouw praktijk dat zij mee wilden werken en commentaar gaven op de 
toenmalige versie van de zelfhulphandleiding. Berend Terluin, jij was trainer van 
de NHG-standaard behandeling en was bedreven in het uitvoeren van deze 
behandeling bij meerdere patiënten tijdens de onderzoeksperiode. Joan Boeke, jij 
was en bent nog steeds zeer enthousiast over de zelfhulpbehandeling. Jij zet ‘het 
beste’ in voor jouw patiënten. 
Meerdere cognitieve gedragstherapeuten werkten mee aan mijn onderzoek. Joost 
Beek, ik gebruikte van jou het deel van jouw handleiding voor Sociale Fobie ‘leren 
ontspannen’. Tevens sprak jij het cassettebandje in. Carla Prick, Louise Prisse, 
Manja de Neef en Inge Sparrius werkten mee met de pilot cognitieve 
gedragstherapie. Sako Visser, Arie Noordam en Marga Kuiper deden vele 
behandelingen tijdens de onderzoeksperiode. Tijdens intervisies hadden we prettig 
contact over hoe behandelingen en samenwerking verliepen. 
Ellen Vedel, jij verving een aantal onderzoekstaken tijdens een jaar van mijn 
opleiding. Josien Schuurmans, jij nam dit met veel enthousiasme over en bent 
doorgegaan met een eigen onderzoek, wat jij reeds voltooid hebt. Ik vond het fijn 
dat jij dit zo prettig voor mij en samen met mij hebt gedaan. Len Hillen en Corine 
Kessel droegen hun steentje bij in de verwerking van de aanmeldingen. 
De patiënten die meewerkten, jullie hebben door jullie inzet het onderzoek doen 
slagen. Ik heb voor jullie openheid en vertrouwen veel bewondering. Jullie wisten 
niet of jullie inzet beloond werd met verbetering van jullie klachten. Fijn was het 
dat jullie dit risico wilden nemen en jullie je wilde inzetten om een nieuwe 
behandelmethode te onderzoeken voor patiënten die na jullie kwamen. 
Met vele medewerkers en onderzoekers van de Valeriuskliniek, het EMGO en het 
EPP heb ik leerzame en gezellige dagen en avonden beleefd tijdens de 
opleidingsmomenten en dagelijkse werkzaamheden. 
Willem van Tilburg, mijn opleider, jij hebt mij met begrip en warmte gesteund om 
de opleiding, onderzoek en privé-leven te combineren. Jaap Veldkamp, mentor 








AGIKO-traject en gaf mede richting aan de te bewandelen weg. Ik vond het erg 
leuk samen met jou muziek te maken. Henriëtte Kuijpers, mijn eerste 
werkbegeleiders tijdens mijn opleiding, jij vond het geen probleem dat ik mijn 
eerste jaar ambulant ging werken. Jij hielp me door deze toch lastige periode heen. 
Jij gaf mij zelfvertrouwen. Ik vond het fijn dat ik jou later in de opleiding nog sprak 
als mentor toen Jaap Veldkamp weg ging. Aartjan Beekman, gedurende een jaar 
heb ik van jou geleerd te werken op een opname en vervolgafdeling en daarnaast 
het onderzoek niet los te laten. En erg leuk dat jij ‘ja’ gezegd hebt om plaats te 
nemen in de leescommissie. Lowijs Perquin en Agnieska Ederveen, jullie samen 
maakten een uitdaging van het half jaar dat ik werkte op de gesloten afdeling. 
Robert Schoevers en Marijke Bremmer maakten een beleidsstage mogelijk op 
toenmalige lokatie J.C. de Keyzer. Ik kon door jullie mijn onderzoek voortzetten 
tijdens deze opleidingsperiode. Het was fijn prettige AGIO-collegas te hebben. 
Victor Buwalda, niet alleen de liefde voor de psychiatrie delen we, maar ook voor 
onderzoek doen, hardlopen en een gezin stichten. Ik ben blij dat jij gelijk instemde 
om mijn paranimf te zijn. Ben Ruesink en Eric Beyaert met jullie reisde ik geregeld 
naar de APO. Ik vind het heel fijn dat wij, samen met Marga Rensen en Désirée 
Oosterbaan, nog regelmatig bij elkaar komen als intervisiegroep. 
Jan Smit, jouw meedenken met de inhoud van mijn artikelen heeft mij verder 
gebracht. Heleen Jonker, jij voerde met veel geduld alle data in. Pieter Kempe, 
zonder jou was de dataverwerking op een ramp uitgelopen. Ik hoop binnenkort op 
jouw promotie te mogen komen. 
Ammani Cherpanath, jij werkte in het kader van je wetenschappelijke stage met 
veel enthousiasme en inzet aan het maken van een overzicht van alle artikelen die 
later in een review verwerkt werden. 
Carla Philippus, Anna Westerveld, Mieke Vink en anderen van het secretariaat en 
ondersteunende diensten, jullie hulp bij de logistiek van het onderzoek was 
onmisbaar. Jullie kregen alles voor elkaar. Het regelen van een agenda, een kamer, 
het kopiëren van de zelfhulphandleiding en het aanschaffen van allerlei 
benodigdheden voor het onderzoek. 
Marijke van ter Toolen, het opzoeken en opsturen van artikelen kon ik met een 
gerust hart aan jou overlaten, ook toen ik niet meer op de Valeriuskliniek kwam. Jij 
zorgde ervoor, zelfs als het van ver moest komen. 
Aartjan Beekman, Michiel Hengeveld, Pim Cuypers en Wim Stalman, hartelijk 
dank dat jullie in de leescommissie wilden plaatsnemen. 







De medewerkers van De Gelderse Roos, afdeling volwassen locatie Ede, jullie 
maakten het voor mij mogelijk mijn proefschrift af te schrijven. Dit waardeer ik 
zeer! Jullie zijn voor mij in de afgelopen jaren een heel prettige werkkring 
geworden, net als de deeltijd adolescenten en alle andere collega’s. Team Preventie 
& Innovatie, Rivierenland, jullie werken reeds met de begeleide zelfhulp. Jan 
Spijker, opleider locatie Ede, ik vind het prettig dat wij samen enthousiast zijn over 
onderzoek doen en dat we werken aan de mogelijkheden voor onderzoek en 
opleiding binnen deze locatie. ‘Doornroosje’, wetenschappelijke rubriek DGR in de 
maak, ik vind het fijn dat ik deel uit maak van deze redactie. Er is nog genoeg 
wetenschap te delen in de toekomst. 
Barend en Willy van Boeijen-van der Horst, mijn ouders, jullie stimuleerden mij 
van jongs af aan te leren. Toen ik zuster wilde worden, hebben jullie mij 
gemotiveerd te gaan studeren voor dokter. Jullie hebben een goede start voor mij 
mogelijk gemaakt. Marja, mijn zus en vriendin, jij bent er altijd voor mij, dat vind 
ik heel erg fijn. Ik ben blij dat jij als paranimf naast mij zal ‘staan’. Familie en 
vrienden, jullie toonden al die tijd interesse in mijn onderzoek. Nu het klaar is zie 
ik jullie graag bij de verdediging. 
Stephan, lieverd, jij maakte het voor mij mogelijk te kiezen voor de combinatie 
opleiding en onderzoek. Jij hebt me steeds gesteund door te gaan, ook op 
moeilijkere momenten. De laatste maanden heb jij extra tijd vrijgemaakt, zodat ik 
het onderzoek kon afronden. Tevens heb jij dit boekje heel mooi vormgegeven. 
Lindsay, Jodie, Eric, Anne* en Mila, mijn kinderen, van wie ik heel veel hou. Mijn 
wens een groot gezin te krijgen is vervuld. Ik ben heel blij dat ik nu mama ben van 
jullie allemaal. Geweldig waren de knuffels precies op het moment dat ik echt even 
aan het onderzoek moest werken. Jullie wilden altijd dat ik ‘snel klaar’ zou zijn. Ik 
geniet van jullie. Ik weet nog meer dan voorheen dat al mij gegeven is in dit leven 
zo waardevol is. 
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